Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 38
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2

  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Smalchuk, Daria
  • Stojanovic, Zonan
  • Marín, Alicia|||0000-0002-9358-2120
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Pérez-Cano, Cristina
  • López-Martínez, Anabel
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Solis, Alan Jhunior
  • Arméstar, Fernando|||0000-0002-6374-1418
  • Matllo, Joan
  • Díaz-Fernández, Sergio
  • Romero, Iris
  • Casas, Irma|||0000-0002-5902-5777
  • Strecker, Kevin
  • Preyer, Rosemarie
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Latorre, Irene|||0000-0001-8159-2455
  • Domínguez, José|||0000-0001-7888-0309
The study of specific T-cell responses against SARS-CoV-2 is important for understanding long-term immunity and infection management. The aim of this study was to assess the dual IFN-γ and IL-2 detection, using a SARS-CoV-2 specific fluorescence ELISPOT, in patients undergoing acute disease, during convalescence, and after vaccination. We also evaluated humoral response and compared with T-cells with the aim of correlating both types of responses, and increase the number of specific response detection. Blood samples were drawn from acute COVID-19 patients and convalescent individuals classified according to disease severity; and from unvaccinated and vaccinated uninfected individuals. IgGs against Spike and nucleocapsid, IgMs against nucleocapsid, and neutralizing antibodies were also analyzed. Our results show that IFN-γ in combination with IL-2 increases response detection in acute and convalescent individuals (p = 0.023). In addition, IFN-γ detection can be a useful biomarker for monitoring severe acute patients, as our results indicate that those individuals with a poor outcome have lower levels of this cytokine. In some cases, the lack of cellular immunity is compensated by antibodies, confirming the role of both types of immune responses in infection, and confirming that their dual detection can increase the number of specific response detections. In summary, IFN-γ/IL-2 dual detection is promising for characterizing and assessing the immunization status, and helping in the patient management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Martínez-Planas, Aina
  • Minguell Domingo, Laura
  • Vallmanya, Teresa
  • Méndez Hernández, Maria|||0000-0001-5697-2763
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Baquero-Artigao, Fernando|||0000-0002-6903-3826
  • Rodríguez-Molino, Paula
  • Guillén-Martín, Sara
  • Toro Rueda, Carlos
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Sabriá, Josefina
  • Santos, José Ramón|||0000-0002-0886-7114
  • Puig, Jordi|||0000-0002-4075-0346
  • Domínguez-Álvarez, Marisol
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Altet, Neus
  • Galea, Yolanda
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Bach Griera, Marc|||0000-0001-9845-7225
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Julián, Esther|||0000-0002-6558-3978
  • Torrelles, Jordi B.|||0000-0001-7702-5941
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Domínguez, José|||0000-0001-7888-0309
Background: Diagnosis of nontuberculous mycobacteria (NTM) infections remains a challenge. In this study, we describe the evaluation of an immunological NTM-interferon (IFN)-γ release assay (IGRA) that we developed using glycopeptidolipids (GPLs) as NTM-specific antigens. Methods: We tested the NTM-IGRA in 99 samples from pediatric patients. Seventy-five were patients with lymphadenitis: 25 were NTM confirmed, 45 were of unknown etiology but compatible with mycobacterial infection and 5 had lymphadenitis caused by an etiologic agent other than NTM. The remaining 24 samples were from control individuals without lymphadenitis (latently infected with M.Tuberculosis, uninfected controls and active tuberculosis patients). Peripheral blood mononuclear cells were stimulated overnight with GPLs. Detection of IFN-γ producing cells was evaluated by enzyme-linked immunospot assay. Results: NTM culture-confirmed lymphadenitis patient samples had a significantly higher response to GPLs than the patients with lymphadenitis of unknown etiology but compatible with mycobacterial infection (P < 0.001) and lymphadenitis not caused by NTM (P < 0.01). We analyzed the response against GPLs in samples from unknown etiology lymphadenitis but compatible with mycobacterial infection cases according to the tuberculin skin test (TST) response, and although not statistically significant, those with a TST ≥5 mm had a higher response to GPLs when compared with the TST <5 mm group. Conclusions: Stimulation with GPLs yielded promising results in detecting NTM infection in pediatric patients with lymphadenitis. Our results indicate that the test could be useful to guide the diagnosis of pediatric lymphadenitis. This new NTM-IGRA could improve the clinical handling of NTM-infected patients and avoid unnecessary misdiagnosis and treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity

  • Cuyàs, Elisabet|||0000-0001-5353-440X
  • Pedarra, Stefano
  • Verdura, Sara|||0000-0001-8980-0423
  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Espin Garcia, Roderic|||0000-0003-2494-0964
  • Serrano-Hervás, Eila|||0000-0002-9477-0350
  • Llop-Hernández, Àngela
  • Teixidor, Eduard
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • López-Bonet, Eugeni
  • Martin-Castillo, Begoña
  • Lupu, Ruth|||0000-0002-5564-3172
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Sardanyés, Josep|||0000-0001-7225-5158
  • Alarcón Cor, Tomás|||0000-0002-8566-3676
  • Menéndez, Javier A.|||0000-0001-8733-4561
Fatty acid synthase (FASN)-catalyzed endogenous lipogenesis is a hallmark of cancer metabolism. However, whether FASN is an intrinsic mechanism of tumor cell defense against T cell immunity remains unexplored. To test this hypothesis, here we combined bioinformatic analysis of the FASN-related immune cell landscape, real-time assessment of cell-based immunotherapy efficacy in CRISPR/Cas9-based FASN gene knockout (FASN KO) cell models, and mathematical and mechanistic evaluation of FASN-driven immunoresistance. FASN expression negatively correlates with infiltrating immune cells associated with cancer suppression, cytolytic activity signatures, and HLA-I expression. Cancer cells engineered to carry a loss-of-function mutation in FASN exhibit an enhanced cytolytic response and an accelerated extinction kinetics upon interaction with cytokine-activated T cells. Depletion of FASN results in reduced carrying capacity, accompanied by the suppression of mitochondrial OXPHOS and strong downregulation of electron transport chain complexes. Targeted FASN depletion primes cancer cells for mitochondrial apoptosis as it synergizes with BCL-2/BCL-X-targeting BH3 mimetics to render cancer cells more susceptible to T-cell-mediated killing. FASN depletion prevents adaptive induction of PD-L1 in response to interferon-gamma and reduces constitutive overexpression of PD-L1 by abolishing PD-L1 post-translational palmitoylation. FASN is a novel tumor cell-intrinsic metabolic checkpoint that restricts T cell immunity and may be exploited to improve the efficacy of T cell-based immunotherapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of endoplasmic reticulum stress-associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm

  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Cáncer, Susana
  • Pérez-Marlasca, Elvira|||0000-0001-9815-198X
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Martínez-González, José|||0000-0002-3894-7166
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Galán, María|||0000-0002-4758-8388
Endoplasmic reticulum (ER) stress plays a critical role in the abdominal aortic aneurysm (AAA), a life-threatening disease characterized by inflammation, destructive remodeling, and vascular smooth muscle cells (VSMCs) dysfunction. The current therapy relies on surgical repair, but no effective pharmacological strategies are available to limit aneurysm progression. Long non-coding RNAs (lncRNAs) are essential factors in health and disease; however, their specific contribution to AAA development and its relationship with ER stress remain unexplored. Here, we have performed a whole-genome transcriptomic analysis characterizing the expression profile of lncRNAs in AAA. RNA sequencing was carried out in abdominal aorta from patients with AAA and healthy donors. We identified 6576 differentially expressed (DE)-mRNAs and 1283 DE-lncRNAs. Interestingly, bioinformatic analysis revealed a set of 368 DE-lncRNAs related to ER stress. The differential expression of the most induced lncRNAs (IL-21-AS1, ITPKB-IT, PCED1B-AS1, TCL-6, LINC00494, LINC00582, LINC00626, LINC00861, and LINC00892) was validated in a large cohort of patients with AAA. The ability of these selected lncRNAs to discriminate patients with AAA from healthy subjects was established by receiveroperating characteristic curves and logistic regression analysis. In human aortic VSMC and Jurkat T-cells, tunicamycin-induced ER stress triggered the expression of IL21-AS1, LINC00626, LINC00494, LINC00892, PCED1B-AS1, ITPKB-IT, and TCL-6, while tauroursodeoxycholic acid counteracted these effects. Finally, an integrated analysis of mRNA-lncRNA co-expression revealed the correlation between the selected lncRNAs and the DE-mRNAs involved in immune response and muscle contraction. Therefore, these DE-lncRNAs potentially implicated in the ER stress response, a pathological process in AAA, could be considered as potential therapeutic target to handle AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease

  • Bernhardt, Alexander Maximilian
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Arriola Infante, José Enrique|||0000-0002-3298-4601
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Longen, Sebastian
  • Trossbach, Svenja Verena
  • Giese, Armin
  • Matthias, Torsten
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Sanjuan, Aída
  • Fernández, Susana|||0000-0002-9777-1156
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Aranha, Mateus|||0000-0001-9594-292X
  • Morcillo Nieto, Alejandra O.|||0000-0003-2202-3521
  • Nübling, Georg|||0000-0003-4492-7302
  • Wagemann, Olivia
  • Stockbauer, Anna
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Fortea, Juan|||0000-0002-1340-638X
  • Levin, Johannes|||0000-0001-5092-4306
Alpha-synuclein (αSyn) seed amplification assay (SAA) enables in vivo study of αSyn but remains underexplored in Down syndrome-associated Alzheimer's disease (DSAD). We analyzed αSyn-SAA in cerebrospinal fluid (CSF) from 270 adults with Down syndrome, from the Down Alzheimer Barcelona Neuroimaging Initiative and from the AD21 cohort from the Department of Neurology at the University Hospital, Ludwig Maximilian University of Munich, Germany. Neuropathological examinations were conducted in 19 brain donors (five with ante mortem CSF). Participants were classified as asymptomatic or symptomatic (prodromal/dementia) Alzheimer's disease (AD). CSF Aβ1-42/1-40, CSF and plasma p-Tau181, and neurofilament light chain (NfL) levels were measured. Neuropathological evaluations assessed AD neuropathological changes and Lewy body pathology (LBP). ΑSyn-SAA was positive in 9.2% of cases, independent of age or cognitive status. Symptomatic αSyn-positive cases exhibited higher plasma NfL levels than αSyn-negative cases (31 vs 21 pg/mL, p = 0.027). LBP was observed in 47% of necropsies. The individual with severe neocortical LBP was αSyn-SAA-positive. These findings highlight LBP prevalence in DSAD but suggest current SAA may fail to detect limited αSyn deposition.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients

  • Pino-Gonzalez, Manuel
  • Lazaro-Quintela, Martin
  • Alonso-Alvarez, Irene
  • Gallardo-Gomez, Maria
  • Juaneda-Magdalena, Laura
  • Francisco-Fernandez, Alejandro
  • Calabuig-Farinas, Silvia
  • Martinez-Fernandez, Monica
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Immunotherapy has opened new avenues of treatment for patients with advanced non-small cell lung cancer (NSCLC) without previous hope of survival. Unfortunately, only a small percentage of patients benefit from it and there is not an effective biomarker to predict patients' response. Since T cells are key effectors of antitumor immunity, T cell receptor (TCR) has emerged as a potential predictive biomarker. Here, we evaluated the potential of baseline TCR repertoire, as a predictive biomarker in advanced NSCLC patients treated with pembrolizumab at first-line. After obtaining peripheral blood and tissue samples at baseline, next-generation sequencing targeting TCR beta/gamma was performed. We found an uneven tumor-infiltrating TCR beta repertoire, and the use of various tumor-infiltrating and circulating TRBV/J genes were able of predicting the immunotherapy response. Our results support the potential of evaluating tissue and circulating TCR beta repertoire prior to pembrolizumab, revealing it as a promising immunotherapy response biomarker in NSCLC patients., This work was supported by the Instituto de Salud Carlos III (ISCIII) and cofunded by European Union under Grants PI21/00348 and CP20/00188. MPG is currently supported by the predoctoral fellowship from Ministerio de Ciencia, Innovacion y Universidaders (FPU23/00744) and previously supported by the Axencia Galega de Innovacion-GAIN (Xunta de Galicia) under Grant for the predoctoral stage IN606A-2024/017. MGG is currently supported by the Axencia Galega de Innovacion-GAIN (Xunta de Galicia) under Grant for the postdoctoral stage IN606B-2024/014. MMF is currently supported by the Instituto de Salud Carlos III (ISCIII) under the Miguel Servet program CP20/00188.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA

  • Trinidad, Eva María
  • Vidal, Enrique
  • Coronado, Ester
  • Esteve-Codina, Anna
  • Castel, Victoria
  • Cañete, Adela
  • Gut, Marta
  • Heath, Simon
  • Font de Mora, Jaime
[EN] Analysis of the methylome of tumor cell-free deoxyribonucleic acid (DNA; cfDNA) has emerged as a powerful non-invasive technique for cancer subtyping and prognosis. However, its application is frequently hampered by the quality and total cfDNA yield. Here, we demonstrate the feasibility of very low-input cfDNA for whole-methylome and copy-number profiling studies using enzymatic conversion of unmethylated cysteines [enzymatic methyl-seq (EM-seq)] to better preserve DNA integrity. We created a model for predicting genomic subtyping and prognosis with high accuracy. We validated our tool by comparing whole-genome CpG sequencing with in situ cohorts generated with bisulfite conversion and array hybridization, demonstrating that, despite the different techniques and sample origins, information on cfDNA methylation is comparable with in situ cohorts. Our findings support use of liquid biopsy followed by EM-seq to assess methylome of cancer patients, enabling validation in external cohorts. This advance is particularly relevant for rare cancers like neuroblastomas where liquid-biopsy volume is restricted by ethical regulations in pediatric patients., TRANSCAN-2 consortium LIQUIDHOPE by Fundación Científica de la Asociación Española Contra el Cáncer (TRNSC18001FON); Spanish Ministry of Science and Innovation (MICINN, PID2020- 119323RB-I00 grant); Sumemos muchas manos por los niños enfermos non-profit organization; Instituto de Salud Carlos III (ISCIII), Spain and European Social Fund Plus (ESF+) of the European Union (Miguel Servet Program, CP20/00179, ISCIII-MICINN to E.V.); Fundación Científica de la Asociación Española Contra el Cáncer (PRDVA19004CORO to E.C.).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

ExcludonFinder: mapping transcriptional overlaps between neighboring genes

  • San Martín Bernal, Álvaro
  • Iturbe Sanz, Pablo
  • Rodríguez-Beltrán, Jerónimo
  • Lasa Uzcudun, Íñigo
Bacteria regulate neighboring genes via overlapping transcription in untranslated regions (UTRs), forming excludons. This overlap leads to transcriptional interference and RNase III-mediated mRNA degradation, resulting in mutually exclusive gene expression, where the activation of one gene suppresses its neighbor. Although individual examples of excludons have been described in various bacterial species, a comprehensive excludon map of a bacterial genome has yet to be established. In this study, we constructed the excludon map of Escherichia coli and Staphylococcus aureus using publicly available RNA-seq data and a newly developed computational tool, ExcludonFinder (https://excludonfinder-unavarra.com). Our analysis identified 16 divergent and 165 convergent excludons in E. coli, as well as 10 divergent and 28 convergent excludons in S. aureus. To validate these findings, we used four independent datasets: detection of double-stranded RNA capture via the Tombusvirus p19 protein, accumulation of short RNAs from RNase III activity, overlap with predicted transcriptional terminators, and single-cell expression analysis. As a proof of concept, we examined transcriptional changes in E. coli under antibiotic stress, revealing that the relBE-ydfV excludon exhibits opposing expression patterns in response to multiple antibiotics. Our findings reveal the widespread presence of excludons and their broad relevance in bacterial gene regulation., Ministerio de Ciencia y Tecnología (Grant/Award Number: PID2020-113494RB-I00); Gobierno de Navarra (MEPERTROBE, Grant/award Number: PC098-099); Instituto de Salud Carlos III (Grant/Award Number: CP20/00154). Source of Open Access funding: Funding to pay the Open Access publication charges for this article was provided by Grants Funding.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

The study of immunological markers in tuberculosis across animal models and its translation to human research

  • Díaz-Fernández, Sergio
  • Aleluia, Matilde
  • Saraiva, Margarida
  • Soldevilla, Pablo
  • Torrelles, Jordi B.
  • Sharan, Riti
  • Verreck, Frank A. W.
  • Izzo, Angelo
  • Vidal, Maria
  • Moreira, Ana C.
  • Pérez de Val, Bernat
  • Roca, Francisco Jose
  • Preda, Madalina
  • Torrents, Eduard
  • Julián, Esther
  • Domínguez, José
  • Latorre, Irene
Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis, remains one of the major causes of death from infection worldwide, with over a million associated deaths each year. The study of biomarkers for TB is critical for advancing our understanding and management of the disease. Biomarkers, defined as measurable indicators of biological states or conditions, are invaluable for the diagnosis, prognosis and treatment monitoring of TB. Clinical studies have provided critical knowledge on the matter but are also notoriously constrained by economical, ethical and sampling limitations. The use of animal models provides a simpler, more controllable, cost-effective setting with great potential for translation to humans. They also allow the evaluation of biomarkers within the respiratory compartment, when available, which is of particular interest due to the nature of TB pathogenesis. This Review focuses on the current landscape of TB biomarker discovery in several animal models, from invertebrates to large mammals. Here we summarize the basics of host–pathogen immune interaction, describe the main methodological approaches used and highlight the most substantial findings for each animal model studied. Furthermore, we discuss the advantages, challenges and limitations associated with species-specific differences in animal models. We conclude that integrating the data obtained from animal models and human studies is absolutely required to advance the TB field to accelerate the management of this disease., This article is based upon work from COST Action ‘Towards an improvement in diagnostics and treatment strategies for TB control’ (ADVANCE-TB), CA21164, supported by COST (European Cooperation in Science and Technology). This work has been also supported by grants from the Instituto de Salud Carlos III (PI21/00724, PI22/01834 and CP20/00070 to I.L.) integrated in the Plan Nacional I+D+I and co-founded by the ISCIII Subdireccion General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER) and CERCA Programme/Generalitat de Catalunya. F.J.R. is the recipient of ‘la Caixa’ Foundation grant LCF/PR/HR21-00368, MCIN and ‘ESF Investing in your Future’ grants RYC2019-027799-I/AEI/10.13039/501100011033 and PID2022-139754OB-100, and a Robles Chillida Foundation Grant. The Institute of Agrifood Research and Technology (IRTA) is supported by CERCA Programme/Generalitat de Catalunya. J.B.T. was partially supported by the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation. R.S. is recipient of National Institutes of Health (NIH) awards K01OD031898, R21AI170148 and R56AI184089-01A1, and other institutional grants P30 AI-161943 (Texas D-CFAR). J.B.T. and R.S. are part of IN-TRAC P30AI168439. E.J. and E.T. are recipients of grants from the Ministerio de Ciencia, Innovación y Universidades and Agencia Estatal de Investigación (AEI), Spain, cofunded by Fondo Europeo de Desarrollo Regional, FEDER, European Union (PID2021-122331OB-I00 and PID2021-125801OB-100) and AGAUR-Generalitat de Catalunya (2021SGR-0092 and 2021SGR-0145). E.J. is a Serra Hunter Fellow., info:eu-repo/semantics/publishedVersion
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

  • de Gonzalo Calvo, David
  • Molinero, Marta
  • Benítez, Iván D.
  • Perez Pons, Manel
  • García Mateo, Nadia
  • Ortega, Alicia
  • Postigo, Tamara
  • García Hidalgo, María C.
  • Belmonte, Thalía
  • Rodríguez Muñoz, Carlos
  • González, Jessica
  • Torres, Gerard
  • Gort Paniello, Clara
  • Moncusí Moix, Anna
  • Estella García, Ángel
  • Tamayo Lomas, Luis
  • Martínez de la Gándara, Amalia
  • Socias, Lorenzo
  • Peñasco, Yhivian
  • de la Torre, María del Carmen
  • Bustamante Munguira, Elena
  • Gallego Curto, Elena
  • Martínez Varela, Ignacio
  • Martín Delgado, María Cruz
  • Vidal Cortés, Pablo
  • López Messa, Juan
  • Pérez García, Felipe
  • Caballero, Jesús
  • Añón, José Manuel
  • Loza Vázquez, Ana
  • Carbonell, Nieves
  • Marin Corral, Judith
  • Jorge García, Ruth Noemí
  • Barberà, Carmen
  • Ceccato, Adrián
  • Fernández Barat, Laia
  • Ferrer, Ricard
  • García Gasulla, Dario
  • Lorente Balanza, Jose Ángel
  • Menéndez, Rosario
  • Motos, Ana
  • Peñuelas, Oscar
  • Riera, Jordi
  • Bermejo Martin, Jesús F.
  • Torres, Antoni
  • Barbé, Ferrán
Background: The identification of critically ill COVID-19 patients at risk of fatal outcomes remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers for clinical decision-making in critically ill patients. Second, we constructed a blood miRNA classifier for the early prediction of adverse outcomes in the ICU. Methods: This was a multicenter, observational and retrospective/prospective study including 503 critically ill patients admitted to the ICU from 19 hospitals. qPCR assays were performed in plasma samples collected within the first 48 h upon admission. A 16-miRNA panel was designed based on recently published data from our group. Results: Nine miRNAs were validated as biomarkers of all-cause in-ICU mortality in the independent cohort of critically ill patients (FDR < 0.05). Cox regression analysis revealed that low expression levels of eight miRNAs were associated with a higher risk of death (HR from 1.56 to 2.61). LASSO regression for variable selection was used to construct a miRNA classifier. A 4-blood miRNA signature composed of miR-16-5p, miR-192-5p, miR-323a-3p and miR-451a predicts the risk of all-cause in-ICU mortality (HR 2.5). Kaplan‒Meier analysis confirmed these findings. The miRNA signature provides a significant increase in the prognostic capacity of conventional scores, APACHE-II (C-index 0.71, DeLong test p-value 0.055) and SOFA (C-index 0.67, DeLong test p-value 0.001), and a risk model based on clinical predictors (C-index 0.74, DeLong test-p-value 0.035). For 28-day and 90-day mortality, the classifier also improved the prognostic value of APACHE-II, SOFA and the clinical model. The association between the classifier and mortality persisted even after multivariable adjustment. The functional analysis reported biological pathways involved in SARS-CoV infection and inflammatory, fibrotic and transcriptional pathways. Conclusions: A blood miRNA classifier improves the early prediction of fatal outcomes in critically ill COVID-19 patients., 11 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Effects of the inclusion of physical activity in secondary education academic classes on educational indicators and health markers: rationale and methods of the ACTIVE CLASS study

  • González Pérez, María
  • Sánchez Oliva, David
  • Grao Cruces, Alberto
  • Cano-Cañada, E.
  • Martín Acosta, Fátima
  • Muñoz-González, R.
  • Bandera Campos, Francisco José
  • Ruiz-Hermosa, A.
  • Vaquero-Solís, M.
  • Padilla Moledo, María del Carmen
  • Conde de Caveda, Julio
  • Segura Jiménez, Víctor
  • González Ponce, Inmaculada
  • García-Calvo, T.
  • Castro Piñero, José
  • Camiletti Moirón, Daniel
Background: Increasing physical activity (PA) levels and reducing sedentary behaviors in children and adolescents is a need, especially in schools. Active breaks and physically active learning are examples of two emerging methodologies that have been shown to be effective in increasing PA levels and additionally produce improvements in children’s educational markers. However, the evidence in adolescents is very limited. This paper presents the design, measurements, and interventions implemented in the ACTIVE CLASS study, whose objectives are: (i) evaluate the effects of two interventions on PA levels, sedentary time, health-related physical fitness academic indicators, cognition, and markers of psychological health among secondary education students; (ii) evaluate teachers’ and students’ experiences about the implementation of these the two school-based PA intervention. Methods: A randomized controlled study is conducted with a total of 292 students aged 12–14 years old from six schools (7th and 8th grade) in Spain (three in Cadiz and three in Caceres). One school from each study provinces is randomly assigned to either the active break intervention group, the physically active learning intervention group, or the control group. The interventions have a duration of 16 weeks. Nine main measurement categories are assessed: PA and sedentary time, health-related physical fitness, academic indicators, cognition, psychological health, motivational variables, dietary patterns, sociodemographic characteristics, as well as qualitative information through semi-structured individual interviews and focus groups. Three independent measurements of evaluation are distinguished: pre-intervention, post-intervention (week 16) and retention measurement (4 weeks after the intervention). For quantitative variables, descriptive, correlational, regression and repeated measures ANOVA will be applied. Discussion: To the best of our knowledge, the ACTIVE CLASS study is the first of its kind in Spain to evaluate the effects of incorporating active breaks and physically active learning in secondary education. In addition, this project provides important information on the effects of two school-based PA intervention arms on educational variables and health markers in adolescents. This will provide valuable and innovative training to the educational community, enabling them to implement teaching methodologies that have the potential to enhance academic performance and improve the quality of life for their students. Clinical trial registration: clinicaltrials.gov, NCT05891054., 10 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Longitudinal reallocations of time between 24-h movement behaviours and their associations with inflammation in children and adolescents: the UP&DOWN study

  • Segura Jiménez, Víctor
  • Pedišić, Željko
  • Gába, Aleš
  • Dumuid, Dorothea
  • Olds, Timothy
  • Štefelová, Nikola
  • Hron, Karel
  • Gómez‑Martínez, Sonia
  • Marcos, Ascensión
  • Castro Piñero, José
Background: While there is evidence that physical activity, sedentary behaviour (SB) and sleep may all be associated with modified levels of inflammatory markers in adolescents and children, associations with one movement behaviour have not always been adjusted for other movement behaviours, and few studies have considered all movement behaviours in the 24-hour day as an exposure. Purpose: The aim of the study was to explore how longitudinal reallocations of time between moderate-to-vigorous physical activity (MVPA), light physical activity (LPA), SB and sleep are associated with changes in inflammatory markers in children and adolescents. Methods: A total of 296 children/adolescents participated in a prospective cohort study with a 3-year follow-up. MVPA, LPA and SB were assessed by accelerometers. Sleep duration was assessed using the Health Behavior in School-aged Children questionnaire. Longitudinal compositional regression models were used to explore how reallocations of time between movement behaviours are associated with changes in inflammatory markers. Results: Reallocations of time from SB to sleep were associated with increases in C3 levels (difference for 60 min/d reallocation [d 60] = 5.29 mg/dl; 95% confidence interval [CI] = 0.28, 10.29) and TNF-α (d 60 = 1.81 mg/dl; 95% CI = 0.79, 15.41) levels. Reallocations from LPA to sleep were also associated with increases in C3 levels (d 60 = 8.10 mg/dl; 95% CI = 0.79, 15.41). Reallocations from LPA to any of the remaining time-use components were associated with increases in C4 levels (d 60 ranging from 2.54 to 3.63 mg/dl; p < 0.05), while any reallocation of time away from MVPA was associated with unfavourable changes in leptin (d 60 ranging from 3088.44 to 3448.07 pg/ml; p < 0.05). Conclusions: Reallocations of time between 24-h movement behaviours are prospectively associated with some inflammatory markers. Reallocating time away from LPA appears to be most consistently unfavourably associated with inflammatory markers. Given that higher levels of inflammation during childhood and adolescence are associated with an increased risk of chronic diseases in adulthood, children and adolescents should be encouraged to maintain or increase the level of LPA to preserve a healthy immune system., 12 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Longitudinal association of sedentary time and physical activity with pain and quality of life in fibromyalgia

  • Gavilán Carrera, Blanca
  • Delgado Fernández, Manuel
  • Álvarez Gallardo, Inmaculada Concepción
  • Acosta Manzano, Pedro
  • Borges Cosic, Milkana María
  • Estévez López, Fernando
  • Soriano Maldonado, Alberto
  • Carbonell Baeza, Ana
  • Aparicio, Virginia A.
  • Segura Jiménez, Víctor
Objective: To analyze changes over time and the predictive value of baseline and changes of sedentary time (ST) and physical activity (PA) on pain, disease impact, and health-related quality of life (HRQoL) at 2- and 5-year follow-up in women with fibromyalgia. Methods: This is a longitudinal and exploratory study with three time points. A total of 427 women with fibromyalgia (51.4 ± 7.6 years) were followed after 2 (n = 172) and 5 years (n = 185). ST and PA (light and moderate-to-vigorous [MVPA]) were assessed using triaxial accelerometers. Pain, disease impact, and HRQoL were measured using: pressure pain threshold, the pain subscale of the revised fibromyalgia impact questionnaire (FIQR), the bodily pain subscale of the 36-item short-form health survey (SF-36), a visual analog scale (VAS), the FIQR, and the SF-36 physical and mental components. Results: Over 5 years, pressure pain threshold, ST, light PA, and MVPA variables were worsened, while FIQR and SF-36 variables were improved (Cohen's d < 0.1–0.3). Baseline ST or light PA were not associated with future outcomes, whereas greater MVPA at baseline was associated with better SF-36 bodily pain at 5-year follow-up (β = 0.13). Reducing ST and increasing light PA were associated with better bodily pain (β = −0.16 and 0.17, respectively) and SF-36 physical component (β = −0.20 and 0.17, respectively) at 5-year follow-up. Increasing MVPA was associated with less pain (pressure pain threshold, VAS, and FIQR-pain) and better SF-36 physical component at 2- and 5-year follow-up (β's from −0.20 to 0.21). Conclusions: Objectively measured variables slightly worsened over years, while for self-reported outcomes there was a trend for improvement. Reductions in ST and increases in light PA and MVPA were associated with better HRQoL at 5-year follow-up, and increases in MVPA were additionally associated with better pain and HRQoL at 2-year follow-up., 15 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Convergent Validation of a Self-Reported Commuting to and from School Diary in Spanish Adolescents

  • Gálvez Fernández, Patricia
  • Herrador Colmenero, Manuel
  • Campos Garzón, Pablo
  • Molina Soberanes, Daniel
  • Saucedo Araujo, Romina Gisele
  • Aranda Balboa, María Jesús
  • Lara Sánchez, Amador Jesús
  • Segura Jiménez, Víctor
  • Henriksson, Pontus
  • Chillón, Palma
The aim of this study was to examine the convergent validity of self-reported diary times for commuting to and from school with device-measured positional data (Global Positioning System; GPS) in Spanish adolescents. Methods: Cross-sectional data were obtained from four Spanish public secondary schools in 2021, comprising 47 adolescents and 141 home–school and school–home trips. Participants self-reported the time they left and arrived at home and school through a commuting diary. They wore a GPS device recording the objective time during three trips (i.e., one home–school trip and two school–home trips). Agreement between commuting diary and GPS data regarding home–school trips and school–home trips was evaluated using Bland–Altman plots. Results: Total commuting time differed by 1 min (95% limits of agreement were 16.1 min and −18.1 min) between subjective and objective measures (adolescents reported 0.8 more minutes in home–school trips and 1 more minute in school–home trips compared to objective data). Passive commuters reported 0.7 more minutes and active commuters reported 1.2 more minutes in the total commuting time compared to objective data. Conclusions: Self-reported commuting diaries may be a useful tool to obtain commuting times of adolescents in epidemiological research or when tools to measure objective times are not feasible, 15 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Association of Moderate-to-Vigorous Physical Activity, Sedentary Time, Fat Percentage, and Physical Fitness with Gait Parameters in Women with Fibromyalgia: The Al-Ándalus Project

  • Llorente-Romero, S.
  • Herrador Colmenero, Manuel
  • Acosta Manzano, Pedro
  • Borges Cosic, Milkana María
  • Gavilán Carrera, Blanca
  • Latorre Román, P.A.
  • Delgado Fernández, Manuel
  • Segura Jiménez, Víctor
Gait impairments have been found in women with fibromyalgia, reducing the physical activity possibilities in this population and leading to a negative correlation with fibromyalgia impact. The aim of this study was to analyze the individual and independent associations of moderate-tovigorous physical activity (MVPA), sedentary time, fat percentage, and physical fitness with gait parameters in women with fibromyalgia. A total of 84 women with fibromyalgia were included. MVPA and sedentary time were assessed with accelerometry, fat percentage with bioimpedance analysis, and physical fitness with field-based fitness tests. Gait was assessed during a “6 min walk test” and categorized in velocity, cadence, step length, step cycle duration, unipedal stance phase, and bipedal stance phase. Individual relationships were analyzed by partial correlations and independent relationships by linear regressions, adjusting by age and height. MVPA, sedentary time, fat percentage, and physical fitness were correlated with most gait parameters (rpartial between |0.842| and |0.219|; p ≤ 0.05). Physical fitness was independently associated with all gait parameters (β between |0.346| and |0.761|; p ≤ 0.002). In addition, MVPA was independently associated with velocity and step length (β = 0.241 and 0.292; both p = 0.004), and fat percentage was associated with bipedal stance phase (β = 0.242; p = 0.049). Good levels of MVPA, physical fitness, and adequate weight balance are associated with improved gait parameters in women with fibromyalgia.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

  • González, Jessica
  • Batlle, Jordi
  • Benítez, Iván D.
  • Torres, Gerard
  • Santisteve, Sally
  • Targa, Adriano D.S.
  • Gort Paniello, Clara
  • Moncusí Moix, Anna
  • Aguilà, Maria
  • Seck, Fatty
  • Ceccato, Adrián
  • Ferrer, Ricard
  • Motos, Anna
  • Riera, Jordi
  • Fernández, Laia
  • Menéndez, Rosario
  • Lorente, José A.
  • Peñuelas, Oscar
  • García Gasulla, Dario
  • Peñasco, Yhivian
  • Ricart, Pilar
  • Abril Palomares, Elena
  • Aguilera, Luciano
  • Rodríguez, Alejandro
  • Boado Varela, Maria Victoria
  • Beteré, Belén
  • Pozo-Laderas, Juan Carlos
  • Solé Violán, Jordi
  • Salvador-Adell, Inmaculada
  • Andrea Novo, Mariana
  • Barberán, José
  • Amaya Villar, Rosario
  • Garnacho-Montero, José
  • Gómez, José M.
  • Blandino Ortiz, Aaron
  • Tamayo Lomas, Luis
  • Úbeda, Alejandro
  • Catalán‑González, Mercedes
  • Sánchez Miralles, Ángel
  • Gumucio-Sanguino, Víctor D.
  • Bustamante Munguira, Elena
  • Valdivia, Luis Jorge
  • Caballero, Jesús
  • Gallego, Elena
  • Rodríguez, Covadonga
  • Castellanos Ortega, Álvaro
  • Trenado, Josep
  • Marin Corral, Judith
  • Albaiceta, Guillermo M.
  • de la Torre, María del Carmen
  • Loza Vázquez, Ana
  • Vidal, Pablo
  • Añón, José Manuel
  • Carbajales Pérez, Cristina
  • Sagredo, Víctor
  • Carbonell, Nieves
  • Socias, Lorenzo
  • Barberà, Carme
  • Estella García, Ángel
  • Díaz, Emili
  • de Gonzalo Calvo, David
  • Torres, Antoni
  • Barbé, Ferrán
  • Cabello, M. A.
  • Alcaraz-Serrano, V.
  • Aldecoa, C.
  • Alegre, C.
  • Calderón, Á. A.
  • Álvarez, S.
  • Bardi, T.
  • Segade, P. B.
  • Barroso, M.
  • García, J.Á.B
  • Bermejo, J.
  • Bigas, J.
  • Blancas, R.
  • Cortés, M. L. B.
  • Saera, M.B.
  • Bofill, N.
  • Vieiro, M.T.B.
  • Bueno, L.
  • Bustamante Munguira, Juan
  • Martínez, C. B. D.
  • Hermoso, D. C.
  • Fernández, S.C.
  • Cano, I.
  • Canseco, J.
  • Fernández, P. C.
  • García, L. C.
  • Carvalho, S.
  • Castellà, M.
  • Castellví, A.
  • Castro, P.
  • Centelles-Serrano, M.J.
  • Ávila, R.C.
  • Cillóniz, C.
  • Clar, L.
  • Climent, C.
  • Codina, J.
  • Conde, P.
  • Contreras, S.
  • Parra, R.D.F.
  • Sánchez, R.D.P.
  • Mendoza, D.D.
  • Díaz, Y.
  • Vilas, M.D.R.
  • Moreno, C.D.
  • Dot, I.
  • Giraudo, P.E.
  • Arijón, I.E.
  • Monjo, T.F.
  • Fernández, J.
  • Ferrando, C.
  • Figueras, A.
  • Gomà, G.
  • Casal, V.G.
  • Gómez, S.
  • Gonzalez, C.G.
  • Gordo, F.
  • Gracia, M.P.
  • Fernández, M.J.G.
  • Herraiz, A.
  • Herrán-Monge, R.
  • Ibarz, M.
  • Iglesias, S.
  • Mantellini, C. L.
  • Naya, G. M.
  • Barcos, I. M.
  • Marcos, P.
  • Peis, E. M.
  • Cuadrado, M. M.
  • Delgado, M. C. M.
  • Vicente, P. M.
  • Martínez, P. M.
  • Fernández, C.E.M.
  • Juan, M. D. M.
  • Palacios, B.M.
  • Jiménez, J. F. M.
  • Masclans, J. R.
  • Maseda, E.
  • Fernández, E. M. M.
  • Banderas, P. M.
  • Mínguez, O.
  • Miralbés, M.
  • Monclou, J.
  • Montejo-González, J. C.
  • Montserrat, N.
  • Aznar, M. M.
  • Morales, D.
  • Cano, S.G.M.
  • Rodríguez, D. M.
  • Muñoz-Bermúdez, R.
  • Nicolás, J.M.
  • Bou, R.N.
  • Salinas, R.N.
  • Ocón, M.
  • Ortega, A.
  • Ossa, S.
  • Pagliarani, P.
  • Parrilla, F.
  • Pedregosa-Díaz, J.
  • Bastida, L. P.
  • Pérez, P.
  • Pérez-García, F.
  • Planelles, G. P.
  • Rubio, E. P.
  • Laguna, D.P.
  • Prados, J.
  • Pujol, A.
  • Coll, N. R.
  • Sánchez-Girón, G.R.
  • Roche-Campo, F.
  • Rodríguez, L.
  • Castro, F. R. D.
  • Rodríguez, S.
  • Ruiz, C. R.
  • Rubio, J.
  • Pensado, M. S.
  • Serra, L.
  • Serra-Fortuny, M.
  • Lázaro, A. S.
  • Servià, L.
  • Soliva, L.
  • Speziale, C.
  • Tormos, A.
  • Torres, M.
  • Tranque-Liberal, C.
  • Trefler, S.
  • Trujillano, J.
  • Vaca, R.
  • Val, E.
  • Ruiz, L. V.
  • Vallverdú, M.
  • Martín-Montalvo, M. V. D. H.
  • Adrio, S.V.
  • Vázquez, N.
  • Vengoechea, J.
  • Vilà-Vilardel, C.
  • Vilanova, J.
  • Warrington, T.V.
  • Yang, H.
  • Yang, M.
  • Zapatero, A.
Introduction: Critical COVID-19 survivors have a high risk of respiratory sequelae. Therefore, we aimed to identify key factors associated with altered lung function and CT scan abnormalities at a follow-up visit in a cohort of critical COVID-19 survivors. Methods: Multicenter ambispective observational study in 52 Spanish intensive care units. Up to 1327 PCR-confirmed critical COVID-19 patients had sociodemographic, anthropometric, comorbidity and lifestyle characteristics collected at hospital admission; clinical and biological parameters throughout hospital stay; and, lung function and CT scan at a follow-up visit. Results: The median [p25–p75] time from discharge to follow-up was 3.57 [2.77–4.92] months. Median age was 60 [53–67] years, 27.8% women. The mean (SD) percentage of predicted diffusing lung capacity for carbon monoxide (DLCO) at follow-up was 72.02 (18.33)% predicted, with 66% of patients having DLCO < 80% and 24% having DLCO < 60%. CT scan showed persistent pulmonary infiltrates, fibrotic lesions, and emphysema in 33%, 25% and 6% of patients, respectively. Key variables associated with DLCO < 60% were chronic lung disease (CLD) (OR: 1.86 (1.18–2.92)), duration of invasive mechanical ventilation (IMV) (OR: 1.56 (1.37–1.77)), age (OR [per-1-SD] (95%CI): 1.39 (1.18–1.63)), urea (OR: 1.16 (0.97–1.39)) and estimated glomerular filtration rate at ICU admission (OR: 0.88 (0.73–1.06)). Bacterial pneumonia (1.62 (1.11–2.35)) and duration of ventilation (NIMV (1.23 (1.06–1.42), IMV (1.21 (1.01–1.45)) and prone positioning (1.17 (0.98–1.39)) were associated with fibrotic lesions. Conclusion: Age and CLD, reflecting patients’ baseline vulnerability, and markers of COVID-19 severity, such as duration of IMV and renal failure, were key factors associated with impaired DLCO and CT abnormalities.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Epigenomic Analysis Reveals a Unique DNA Methylation Program of Metastasis-Competent Circulating Tumor Cells in Colorectal Cancer

  • Bao-Caamano, Aida
  • Costa-Fraga, Nicolás
  • Cayrefourcq, Laure
  • Jácome, M. A.
  • Rodríguez-Casanova, Aitor
  • Muinelo Romay, Laura
  • López-López, Rafael
  • Alix-Panabières, Catherine
  • Díaz-Lagares, Ángel
[Abstract] Circulating tumor cells (CTCs) and epigenetic alterations are involved in the development of metastasis from solid tumors, such as colorectal cancer (CRC). The aim of this study was to characterize the DNA methylation profile of metastasis-competent CTCs in CRC. The DNA methylome of the human CRC-derived cell line CTC-MCC-41 was analyzed and compared with primary (HT29, Caco2, HCT116, RKO) and metastatic (SW620 and COLO205) CRC cells. The association between methylation and the transcriptional profile of CTC-MCC-41 was also evaluated. Differentially methylated CpGs were validated with pyrosequencing and qMSP. Compared to primary and metastatic CRC cells, the methylation profile of CTC-MCC-41 was globally different and characterized by a slight predominance of hypomethylated CpGs mainly distributed in CpG-poor regions. Promoter CpG islands and shore regions of CTC-MCC-41 displayed a unique methylation profile that was associated with the transcriptional program and relevant cancer pathways, mainly Wnt signaling. The epigenetic regulation of relevant genes in CTC-MCC-41 was validated. This study provides new insights into the epigenomic landscape of metastasis-competent CTCs, revealing biological information for metastasis development, as well as new potential biomarkers and therapeutic targets for CRC patients., This research was funded by the ISCIII (PI18/00307) and the European Regional Development Fund (FEDER), and by the Liquid Biopsy Crowdfunding campaign organized by ONCOMET in 2017. We would like to thank all donors who participated in the Liquid Biopsy Crowdfunding campaign organized by ONCOMET in 2017. AB-C is funded by a predoctoral contract PFIS (FI19/00240) from “Instituto de Salud Carlos III” (ISCIII) co-funded by “Fondo Social Europeo” (FSE). NC-F is funded by a predoctoral contract from “Xunta de Galicia” (IN606A-2020/004). AR-C is supported by the Roche-Chus Joint Unit (IN853B 2018/03) funded by “Axencia Galega de Innovación (GAIN), Vicepresidencia Segunda e Consellería de Economía, Empresa e Innovación”. LM-R is funded by a contract “Miguel Servet” from ISCIII (CP20/00129). CA-P is supported by funding from the European Union Horizon 2020 Research and Innovation program under the Marie Skłodowska-Curie grant agreement No. 765492, by The National Institute of Cancer (INCa, http://www.e-cancer.fr), SIRIC Montpellier Cancer Grant INCa_Inserm_DGOS_12553, and the ERA-NET TRANSCAN 2 JTC 2016 PROLIPSY, la Fondation ARC pour la Recherche sur le cancer and les Fonds de dotation AFER pour la recherche médicale. AD-L was funded by a contract “Juan Rodés” (JR17/00016) from “Instituto de Salud Carlos III” (ISCIII) and by Servizo Galego de Saúde (SERGAS). All authors have read the journal's policy on disclosure of potential conflicts of interest, and have disclosed any financial or personal relationship with organizations that could potentially be perceived as influencing the described research, Xunta de Galicia; IN606A-2020/004, Xunta de Galicia; IN853B 2018/03, Francia. Institut National du Cancer; INCa_Inserm_DGOS_12553
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

  • Moreo, Eduardo
  • Jarit-Cabanillas, Aitor
  • Robles-Vera, Iñaki
  • Uranga, Santiago
  • Guerrero, Claudia
  • Gómez, Ana Belén
  • Mata-Martínez, Pablo
  • Minute, Luna
  • Araujo-Voces, Miguel
  • Felgueres, María José
  • Esteso, Gloria
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • Pardo, Julián
  • Martín, Carlos
  • Valés-Gómez, Mar
  • del Fresno, Carlos
  • Sancho, David
  • Aguiló, Nacho
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well-tolerated and effective in preventing tuberculosis infection in animals. Here, we examine IV BCG in several preclinical lung tumor models. Our findings demonstrate that BCG inoculation reduced tumor growth and prolonged mouse survival in models of lung melanoma metastasis and orthotopic lung adenocarcinoma. Moreover, IV BCG treatment was well-tolerated with no apparent signs of acute toxicity. Mechanistically, IV BCG induced tumor-specific CD8+ T cell responses, which were dependent on type 1 conventional dendritic cells, as well as NK cell-mediated immunity. Lastly, we also show that IV BCG has an additive effect on anti-PD-L1 checkpoint inhibitor treatment in mouse lung tumors that are otherwise resistant to anti-PD-L1 as monotherapy. Overall, our study demonstrates the potential of systemic IV BCG administration in the treatment of lung tumors, highlighting its ability to enhance immune responses and augment immune checkpoint blockade efficacy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Conceptualization of depression among medical students and its differences during medical education

  • Arana-Ballestar, Santi
  • Campos-Ródenas, Ricardo
  • Olaya, Beatriz
  • Santabárbara, Javier
The definition of mental disorders has been traditionally a matter of discussion, and it has relevant implications in research and healthcare. Our aim was to explore the conceptualization medical students have of depression and to determine differences across academic years. The Maudsley Attitudes Questionnaire was adapted through a double translation, double back-translation and a preliminary validation, obtaining a Spanish edition. All students of the Faculty of Medicine of the University of Zaragoza and doctors who graduated from this University in 2020 were invited to answer the online questionnaire, and we received 222 answers (response rate: 15.2%). The results were compared by years and levels of education using an ANOVA. The social realist, behavioral, biological, cognitive and psychodynamic models were the most endorsed. The psychodynamic and nihilist models were less embraced by students in later educational years. These students also reported greater confidence in their understanding of depression and of its biological, cognitive and behavioral models. In conclusion, the conceptualization of depression among medical students is complex and multidimensional, and appears to be similar across different years of education. In later years, we found less support for the psychodynamic model, increased confidence in psychiatry and greater ease in handling the concepts of its leading models.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Depression as a risk factor for alzheimer’s disease: A systematic review of longitudinal meta-analyses

  • Sáiz-Vázquez O.
  • Gracia-García P.
  • Ubillos-Landa S.
  • Puente-Martínez A.
  • Casado-Yusta S.
  • Olaya B.
  • Santabárbara J.
Alzheimer’s disease (AD) is the most frequent cause of dementia, linked to morbidity and mortality among elderly patients. Recently, several clinical studies suggested that depression is a potential risk factor for cognitive decline and AD. A review of meta-analyses was performed, calculating pooled odds ratios to estimate the risk of AD in people with a prior diagnosis (or clinically significant symptoms) of depression. A total of six meta-analyses which represented 28 individual studies were analyzed. A significant association between depression and AD was found (OR = 1.54, 95% CI [1.02–2.31]; p = 0.038). The results showed that heterogeneity across studies was substantial. We found a significant positive effect size for clinical measures of depression, but not for symptomatic rating scales, in the association of depression with risk of AD. The type of rating scale used to assess depression and the cut-off criteria selected also moderated the relationship between depression and AD risk. We found that studies that used clinically significant criteria for diagnosis of depression had more consistent and significant results than studies that used symptomatic scales.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The study of immunological markers in tuberculosis across animal models and its translation to human research

  • Díaz-Fernández, Sergio
  • Aleluia, Matilde
  • Saraiva, Margarida
  • Soldevilla, Pablo
  • Torrelles, Jordi B.
  • Sharan, Riti
  • Verreck, Frank A. W.
  • Izzo, Angelo
  • Vidal, Maria
  • Moreira, Ana C.
  • Pérez de Val, Bernat
  • Roca, Francisco Jose
  • Preda, Madalina
  • Torrents, Eduard
  • Julián, Esther
  • Domínguez, José
  • Latorre, Irene
Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis, remains one of the major causes of death from infection worldwide, with over a million associated deaths each year. The study of biomarkers for TB is critical for advancing our understanding and management of the disease. Biomarkers, defined as measurable indicators of biological states or conditions, are invaluable for the diagnosis, prognosis and treatment monitoring of TB. Clinical studies have provided critical knowledge on the matter but are also notoriously constrained by economical, ethical and sampling limitations. The use of animal models provides a simpler, more controllable, cost-effective setting with great potential for translation to humans. They also allow the evaluation of biomarkers within the respiratory compartment, when available, which is of particular interest due to the nature of TB pathogenesis. This Review focuses on the current landscape of TB biomarker discovery in several animal models, from invertebrates to large mammals. Here we summarize the basics of host–pathogen immune interaction, describe the main methodological approaches used and highlight the most substantial findings for each animal model studied. Furthermore, we discuss the advantages, challenges and limitations associated with species-specific differences in animal models. We conclude that integrating the data obtained from animal models and human studies is absolutely required to advance the TB field to accelerate the management of this disease., This article is based upon work from COST Action ‘Towards an improvement in diagnostics and treatment strategies for TB control’ (ADVANCE-TB), CA21164, supported by COST (European Cooperation in Science and Technology). This work has been also supported by grants from the Instituto de Salud Carlos III (PI21/00724, PI22/01834 and CP20/00070 to I.L.) integrated in the Plan Nacional I+D+I and co-founded by the ISCIII Subdireccion General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER) and CERCA Programme/Generalitat de Catalunya. F.J.R. is the recipient of ‘la Caixa’ Foundation grant LCF/PR/HR21-00368, MCIN and ‘ESF Investing in your Future’ grants RYC2019-027799-I/AEI/10.13039/501100011033 and PID2022-139754OB-100, and a Robles Chillida Foundation Grant. The Institute of Agrifood Research and Technology (IRTA) is supported by CERCA Programme/Generalitat de Catalunya. J.B.T. was partially supported by the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation. R.S. is recipient of National Institutes of Health (NIH) awards K01OD031898, R21AI170148 and R56AI184089-01A1, and other institutional grants P30 AI-161943 (Texas D-CFAR). J.B.T. and R.S. are part of IN-TRAC P30AI168439. E.J. and E.T. are recipients of grants from the Ministerio de Ciencia, Innovación y Universidades and Agencia Estatal de Investigación (AEI), Spain, cofunded by Fondo Europeo de Desarrollo Regional, FEDER, European Union (PID2021-122331OB-I00 and PID2021-125801OB-100) and AGAUR-Generalitat de Catalunya (2021SGR-0092 and 2021SGR-0145). E.J. is a Serra Hunter Fellow., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

  • Martin-Loeches, Ignacio|||0000-0002-5834-4063
  • Motos, Ana|||0000-0002-3757-1232
  • Menéndez, Rosario
  • Gabarrús, Albert|||0000-0003-3492-1310
  • González Gutiérrez, Jessica|||0000-0002-6847-5315
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Ceccato, Adrian|||0000-0001-9454-062X
  • Pérez-Arnal, Raquel|||0000-0002-0041-8146
  • Garcia-Gasulla, Dario|||0000-0001-6732-5641
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Riera del Brio, Jordi|||0000-0002-1738-4448
  • Lorente, José Ángel
  • Peñuelas, Óscar
  • Bermejo Martín, Jesús F.|||0000-0002-7998-6268
  • Díaz Santos, Emilio|||0000-0003-3637-3821
  • Rodríguez, Alejandro
  • Barbé, Ferran|||0000-0002-2340-8928
  • Aguilera, Luciano
  • Amaya-Villar, Rosario
  • Barberà, Carme
  • Barberán, José
  • Blandino Ortiz, Aaron|||0000-0002-3184-6418
  • Bustamante-Munguira, Elena
  • Caballero, Jesús|||0000-0001-9005-9687
  • Carbajales, Cristina|||0000-0002-4496-5336
  • Carbonell, Nieves|||0000-0002-9149-0310
  • Catalán-González, Mercedes
  • Galbán, Cristóbal
  • Gumucio-Sanguino, Víctor D.
  • de la Torre, Maria Del Carmen
  • Díaz-Aparicio, Efren
  • Gallego, Elena
  • García Garmendia, José Luis|||0000-0003-1443-9236
  • Garnacho Montero, José|||0000-0003-2542-7601
  • Gómez García, José Manuel|||0009-0002-2154-8043
  • Jorge García, Ruth Noemí
  • Loza-Vázquez, Ana
  • Marín Corral, Judith|||0000-0003-1320-4427
  • Martínez de la Gándara, Amalia
  • Martínez Varela, Ignacio Y.|||0000-0002-2419-3914
  • Lopez Messa, Juan
  • Albaiceta, Guillermo M.|||0000-0002-9276-3253
  • Novo, Mariana Andrea
  • Peñasco, Yhivian
  • Ricart, Pilar|||0000-0003-0067-9132
  • Urrelo-Cerrón, Luis
  • Sánchez Miralles, Ángel
  • Sancho Chinesta, Susana
  • Socias, Lorenzo
  • Sole-Violan, Jordi|||0000-0002-0483-4470
  • Tamayo Lomas, Luis
  • Vidal-Cortés, Pablo|||0000-0003-0225-9975
  • Torres, Antoni|||0000-0002-8643-2167
Background. Some patients previously presenting with COVID-19 have been reported to develop persistent COVID-19 symptoms. While this information has been adequately recognised and extensively published with respect to non-critically ill patients, less is known about the incidence and factors associated with the characteristics of persistent COVID-19. On the other hand, these patients very often have intensive care unit-acquired pneumonia (ICUAP). A second infectious hit after COVID increases the length of ICU stay and mechanical ventilation and could have an influence on poor health post-COVID 19 syndrome in ICU-discharged patients. Methods: This prospective, multicentre, and observational study was carrid out across 40 selected ICUs in Spain. Consecutive patients with COVID-19 requiring ICU admission were recruited and evaluated three months after hospital discharge. Results: A total of 1255 ICU patients were scheduled to be followed up at 3 months; however, the final cohort comprised 991 (78.9%) patients. A total of 315 patients developed ICUAP (97% of them had ventilated ICUAP). Patients requiring invasive mechanical ventilation had more persistent post-COVID-19 symptoms than those who did not require mechanical ventilation. Female sex, duration of ICU stay, development of ICUAP, and ARDS were independent factors for persistent poor health post-COVID-19. Conclusions: Persistent post-COVID-19 symptoms occurred in more than two-thirds of patients. Female sex, duration of ICU stay, development of ICUAP, and ARDS all comprised independent factors for persistent poor health post-COVID-19. Prevention of ICUAP could have beneficial effects in poor health post-COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome

  • Lleó, Alberto|||0000-0002-2568-5478
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Karikari, Thomas K.|||0000-0003-1422-4358
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Montal, Victor|||0000-0002-5714-9282
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Lantero Rodríguez, Juan|||0000-0002-7426-678X
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Benejam, Bessy|||0000-0002-6789-8615
  • Fernández, Susana|||0000-0002-9777-1156
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Garzón, Diana
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Camacho, Valle|||0000-0003-0748-0847
  • Medrano-Martorell, Santiago|||0000-0002-6586-7284
  • Belbin, Olivia|||0000-0002-6109-6371
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Lehmann, Sylvain|||0000-0001-6117-562X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Blesa, Rafael|||0000-0003-4026-2884
  • Blennow, Kaj|||0000-0002-1890-4193
  • Fortea, Juan|||0000-0002-1340-638X
  • Zetterberg, Henrik|||0000-0003-3930-4354
Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology with high accuracy in the general population. In this study, we investigated plasma p-tau181 as a biomarker of AD in individuals with Down syndrome (DS). We included 366 adults with DS (240 asymptomatic, 43 prodromal AD, 83 AD dementia) and 44 euploid cognitively normal controls. We measured plasma p-tau181 with a Single molecule array (Simoa) assay. We examined the diagnostic performance of p-tau181 for the detection of AD and the relationship with other fluid and imaging biomarkers. Plasma p-tau181 concentration showed an area under the curve of 0.80 [95% CI 0.73-0.87] and 0.92 [95% CI 0.89-0.95] for the discrimination between asymptomatic individuals versus those in the prodromal and dementia groups, respectively. Plasma p-tau181 correlated with atrophy and hypometabolism in temporoparietal regions. Our findings indicate that plasma p-tau181 concentration can be useful to detect AD in DS. Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology. Here, the authors investigated whether plasma ptau181 could be a potential biomarker of AD in individuals with Down syndrome (DS) and find plasma p-tau181 can detect AD in DS adults.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management

  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Latorre, Irene|||0000-0001-8159-2455
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Stojanovic, Zorac
  • Marín, Alicia|||0000-0002-9358-2120
  • Pérez-Cano, Cristina
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Solis, Alan Jhurior
  • Arméstar, Fernando|||0000-0002-6374-1418
  • Matllo, Joan
  • Díaz-Fernández, Sergio
  • Cendón Esteve, Arnau
  • Sokalchuk, Liliya
  • Tolosa, Guillermo
  • Casas, Irma|||0000-0002-5902-5777
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Domínguez, José|||0000-0001-7888-0309
The measurement of specific T-cell responses can be a useful tool for COVID-19 diagnostics and clinical management. In this study, we evaluated the IFN-γ T-cell response against the main SARS-CoV-2 antigens (spike, nucleocapsid and membrane) in acute and convalescent individuals classified according to severity, and in vaccinated and unvaccinated controls. IgG against spike and nucleocapsid were also measured. Spike antigen triggered the highest number of T-cell responses. Acute patients showed a low percentage of positive responses when compared to convalescent (71.6% vs. 91.7%, respectively), but increased during hospitalization and with severity. Some convalescent patients showed an IFN-γ T-cell response more than 200 days after diagnosis. Only half of the vaccinated individuals displayed an IFN-γ T-cell response after the second dose. IgG response was found in a higher percentage of individuals compared to IFN-γ T-cell responses, and moderate correlations between both responses were seen. However, in some acute COVID-19 patients specific T-cell response was detected, but not IgG production. We found that the chances of an IFN-γ T-cell response against SARS-CoV-2 is low during acute phase, but may increase over time, and that only half of the vaccinated individuals had an IFN-γ T-cell response after the second dose.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of Mesenchymal Stem/Stromal Cells in Coagulation

  • Guillamat-Prats, Raquel|||0000-0001-6960-0985
Mesenchymal stem/stromal cells (MSCs) are widely used in disease models in order to control several phases in the response to injuries, immune reaction, wound healing, and regeneration. MSCs can act upon both the innate and adaptive immune systems and target a broad number of functions, such as the secretion of cytokines, proteolytic enzymes, angiogenic factors, and the regulating of cell proliferation and survival. The role of MSCs in coagulation has been less studied. This review evaluates the properties and main functions of MSCs in coagulation. MSCs can regulate coagulation in a wide range of pathways. MSCs express and release tissue factors (TF), one of the key regulators of the extrinsic coagulation pathways; MSCs can trigger platelet production and contribute to platelet activation. Altogether, MSCs seem to have a pro-thrombotic role and their superior characterization prior to their administration is necessary in order to prevent adverse coagulation events.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic, a matched analysis

  • Riera del Brio, Jordi|||0000-0002-1738-4448
  • Barbeta, Enric|||0000-0001-9725-4100
  • Tormos, Adrián
  • Mellado Artigas, Ricard|||0000-0003-2815-6819
  • Ceccato, Adrian|||0000-0001-9454-062X
  • Motos, Ana|||0000-0002-3757-1232
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Garcia-Gasulla, Dario|||0000-0001-6732-5641
  • Peñuelas, Oscar|||0000-0003-1484-3933
  • Lorente, José Ángel
  • Menéndez, Rosario
  • Roca Gas, Oriol|||0000-0003-3841-4551
  • Palomeque, Andrea
  • Ferrando, Carlos|||0000-0002-1907-5323
  • Sole-Violan, Jordi|||0000-0002-0483-4470
  • Novo, Mariana
  • Boado Varela, Maria Victoria
  • Tamayo, Luis
  • Estella, Ángel|||0000-0003-0665-557X
  • Galbán, Cristóbal
  • Trenado Álvarez, José|||0000-0002-2930-0766
  • Huerta, Arturo|||0000-0002-6191-4143
  • Loza, Ana
  • Aguilera, Luciano
  • Garmendia, José Luís García
  • Barberà, Carme
  • Gumucio, Víctor
  • Socias, Lorenzo
  • Franco, Nieves
  • Valdivia, Luis Jorge
  • Vidal-Cortés, Pablo|||0000-0003-0225-9975
  • Sagredo, Victor
  • Ruiz-García, Ángela Leonor
  • Varela, Ignacio Martínez
  • López, Juan
  • Pozo, Juan Carlos
  • Nieto, Maite
  • Gómez García, José Manuel|||0009-0002-2154-8043
  • Blandino Ortiz, Aaron|||0000-0002-3184-6418
  • Valledor, Manuel
  • Bustamante-Munguira, Elena
  • Sánchez Miralles, Ángel
  • Peñasco, Yhivian
  • Barberán, José
  • Úbeda, Alejandro
  • Amaya-Villar, Rosario
  • Martín, María Cruz
  • Jorge García, Ruth Noemí
  • Caballero, Jesús|||0000-0001-9005-9687
  • Marín Corral, Judith|||0000-0003-1320-4427
  • Añón, José Manuel
  • Sipmann, Fernando Suárez
  • Muñiz, Guillermo
  • Castellanos Ortega, Álvaro|||0000-0002-8315-2485
  • Adell-Serrano, Berta
  • Catalán-González, Mercedes
  • de la Gándara, Amalia Martínez
  • Ricart, Pilar|||0000-0003-0067-9132
  • Carbajales, Cristina|||0000-0002-4496-5336
  • Rodríguez, Alejandro
  • Díaz Santos, Emilio|||0000-0003-3637-3821
  • de la Torre, Maria Del Carmen
  • Gallego, Elena
  • Cantón-Bulnes, Luisa
  • Carbonell, Nieves|||0000-0002-9149-0310
  • González Gutiérrez, Jessica|||0000-0002-6847-5315
  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Barbé, Ferran|||0000-0002-2340-8928
  • Torres, Antoni|||0000-0002-8643-2167
The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with COVID-19-associated respiratory failure. We also analysed both the impact of such timing throughout the first four pandemic waves and the influence of prior non-invasive respiratory support on outcomes. This is a secondary analysis of a multicentre, observational and prospective cohort study that included all consecutive patients undergoing invasive mechanical ventilation due to COVID-19 from across 58 Spanish intensive care units (ICU) participating in the CIBERESUCICOVID project. The study period was between 29 February 2020 and 31 August 2021. Early intubation was defined as that occurring within the first 24 h of intensive care unit (ICU) admission. Propensity score (PS) matching was used to achieve balance across baseline variables between the early intubation cohort and those patients who were intubated after the first 24 h of ICU admission. Differences in outcomes between early and delayed intubation were also assessed. We performed sensitivity analyses to consider a different timepoint (48 h from ICU admission) for early and delayed intubation. Of the 2725 patients who received invasive mechanical ventilation, a total of 614 matched patients were included in the analysis (307 for each group). In the unmatched population, there were no differences in mortality between the early and delayed groups. After PS matching, patients with delayed intubation presented higher hospital mortality (27.3% versus 37.1%, p =0.01), ICU mortality (25.7% versus 36.1%, p=0.007) and 90-day mortality (30.9% versus 40.2%, p=0.02) when compared to the early intubation group. Very similar findings were observed when we used a 48-hour timepoint for early or delayed intubation. The use of early intubation decreased after the first wave of the pandemic (72%, 49%, 46% and 45% in the first, second, third and fourth wave, respectively; first versus second, third and fourth waves p<0.001). In both the main and sensitivity analyses, hospital mortality was lower in patients receiving high-flow nasal cannula (n=294) who were intubated earlier. The subgroup of patients undergoing NIV (n=214) before intubation showed higher mortality when delayed intubation was set as that occurring after 48 h from ICU admission, but not when after 24 h. In patients with COVID-19 requiring invasive mechanical ventilation, delayed intubation was associated with a higher risk of hospital mortality. The use of early intubation significantly decreased throughout the course of the pandemic. Benefits of such an approach occurred more notably in patients who had received high-flow nasal cannula.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ultra-Processed Foods and Drinks Consumption Is Associated with Psychosocial Functioning in Adolescents

  • Reales-Moreno, Marta|||0000-0003-0677-0164
  • Tonini, Pietro|||0000-0003-3113-619X
  • Escorihuela, Rosa M.|||0000-0001-9368-5173
  • Solanas i Garcia, Montserrat|||0000-0003-2949-1344
  • Fernández-Barrés, Sílvia|||0000-0002-9977-2291
  • Romaguera, Dora|||0000-0002-5762-8558
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
Adolescents show one of the highest rates of ultra-processed foods and drinks (UPF) consumption, and studies indicate an association between their consumption and internalizing problems. We aim to investigate whether UPF consumption associates with dysfunctions in other psychosocial domains, as well as sex effects. In 560 Spanish adolescents (14-17 years old), we assessed the UPF products consumed in the previous day, fruits and vegetables consumption (servings/day), and physical activity (days/week). Psychosocial functioning (total and subscales) was assessed through the Pediatric Symptom Checklist-Youth self-report. Associations between UPF and psychosocial functioning were assessed using linear regression models, adjusting for sex, age, fruits and vegetables consumption, and physical activity. Sex-specific associations were also explored. Participants reported a daily consumption of 7.72 UPF servings per day, with male adolescents showing higher consumption than female adolescents. Consumption of fruits and vegetables and physical activity levels were lower than recommended. Psychosocial impairment was present in 26.2% of the participants. Higher UPF consumption was associated with higher presence of depressive symptoms and internalizing and externalizing problems in the whole sample and in male adolescents. The present study supports previous studies suggesting that UPF consumption may interact with mental health problems and indicates that these effects may go beyond internalizing problems.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of Apolipoprotein e ϵ4 Allele with Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults with down Syndrome

  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Vilaplana, Eduard|||0000-0002-1809-8435
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Fernandez, S.
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Montal, Victor|||0000-0002-5714-9282
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Giménez, Sandra|||0000-0001-8031-2319
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Muñoz, Laia|||0000-0003-0578-3094
  • Padilla, Concepción|||0000-0003-4102-6787
  • Aranha, Mateus|||0000-0001-9594-292X
  • Estellés, Teresa
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Belbin, Olivia|||0000-0002-6109-6371
  • Camacho, Valle|||0000-0003-0748-0847
  • Wilson, Liam Reese
  • Annus, Tiina
  • Osorio, R.S.
  • Videla, S.
  • Lehmann, Sylvain|||0000-0001-6117-562X
  • Holland, Anthony|||0000-0003-4107-130X
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Blennow, Kaj|||0000-0002-1890-4193
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Zaman, Shahid
  • Blesa, Rafael|||0000-0003-4026-2884
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
Importance: Alzheimer disease (AD) is the leading cause of death in individuals with Down syndrome (DS). Previous studies have suggested that the APOE ϵ4 allele plays a role in the risk and age at onset of dementia in DS; however, data on in vivo biomarkers remain scarce. Objective: To investigate the association of the APOE ϵ4 allele with clinical and multimodal biomarkers of AD in adults with DS. Design, Setting, and Participants: This dual-center cohort study recruited adults with DS in Barcelona, Spain, and in Cambridge, UK, between June 1, 2009, and February 28, 2020. Included individuals had been genotyped for APOE and had at least 1 clinical or AD biomarker measurement; 2 individuals were excluded because of the absence of trisomy 21. Participants were either APOE ϵ4 allele carriers or noncarriers. Main Outcomes and Measures: Participants underwent a neurological and neuropsychological assessment. A subset of participants had biomarker measurements: Aβ1-42, Aβ1-40, phosphorylated tau 181 (pTau181) and neurofilament light chain (NfL) in cerebrospinal fluid (CSF), pTau181, and NfL in plasma; amyloid positron emission tomography (PET); fluorine 18-labeled-fluorodeoxyglucose PET; and/or magnetic resonance imaging. Age at symptom onset was compared between APOE ϵ4 allele carriers and noncarriers, and within-group local regression models were used to compare the association of biomarkers with age. Voxelwise analyses were performed to assess topographical differences in gray matter metabolism and volume. Results: Of the 464 adults with DS included in the study, 97 (20.9%) were APOE ϵ4 allele carriers and 367 (79.1%) were noncarriers. No differences between the 2 groups were found by age (median [interquartile range], 45.9 [36.4-50.2] years vs 43.7 [34.9-50.2] years; P =.56) or sex (51 male carriers [52.6%] vs 199 male noncarriers [54.2%]). APOE ϵ4 allele carriers compared with noncarriers presented with AD symptoms at a younger age (mean [SD] age, 50.7 [4.4] years vs 52.7 [5.8] years; P =.02) and showed earlier cognitive decline. Locally estimated scatterplot smoothing curves further showed between-group differences in biomarker trajectories with age as reflected by nonoverlapping CIs. Specifically, carriers showed lower levels of the CSF Aβ1-42 to Aβ1-40 ratio until age 40 years, earlier increases in amyloid PET and plasma pTau181, and earlier loss of cortical metabolism and hippocampal volume. No differences were found in NfL biomarkers or CSF total tau and pTau181. Voxelwise analyses showed lower metabolism in subcortical and parieto-occipital structures and lower medial temporal volume in APOE ϵ4 allele carriers. Conclusions and Relevance: In this study, the APOE ϵ4 allele was associated with earlier clinical and biomarker changes of AD in DS. These results provide insights into the mechanisms by which APOE increases the risk of AD, emphasizing the importance of APOE genotype for future clinical trials in DS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease

  • Benejam, Bessy|||0000-0002-6789-8615
  • Aranha, Mateus|||0000-0001-9594-292X
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Padilla, Concepción|||0000-0003-4102-6787
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Fernández, Susana|||0000-0002-9777-1156
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Montal, Victor|||0000-0002-5714-9282
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Giménez, Sandra|||0000-0001-8031-2319
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Videla, Sebastián|||0000-0001-5049-1379
  • Bartrés-Faz, David|||0000-0001-6020-4118
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Blesa, Rafael|||0000-0003-4026-2884
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
Background: Adults with Down syndrome are at an ultra-high risk of developing early-onset Alzheimer's disease. Episodic memory deficits are one of the earliest signs of the disease, but their association with regional brain atrophy in the population with Down syndrome has not been explored. We aimed to investigate the neuroanatomical correlates of episodic memory in adults with Down syndrome and symptomatic Alzheimer's disease. Methods: Single-center, cross-sectional study. A total of 139 adults with Down syndrome (85 asymptomatic and 54 with symptomatic Alzheimer's disease) were included in the study (mean age 43.6 ± 10.9 years, 46% female). Episodic memory was assessed using the modified Cued Recall Test. Immediate (trial 1 free immediate recall, trial 3 free immediate recall, total free immediate recall score, and total immediate score) and delayed scores (free delayed recall score and total delayed score) were examined. Cortical thickness from magnetic resonance imaging was determined with surface-based morphometry using the FreeSurfer 6.0 software package. The clusters of reduced cortical thickness were compared between symptomatic and asymptomatic participants to create a cortical atrophy map. Then, the correlation between cortical thickness and the modified Cued Recall Test subscores were separately assessed in symptomatic and asymptomatic subjects, controlling for age, sex, and severity of intellectual disability. Results: Compared with asymptomatic participants, those with symptomatic Alzheimer's disease showed a pattern of cortical atrophy in posterior parieto-temporo-occipital cortices. In symptomatic subjects, trial 1 immediate free recall significantly correlated with cortical atrophy in lateral prefrontal regions. Trial 3 free immediate recall and total free immediate recall were associated with the most widespread cortical atrophy. Total immediate score was related to posterior cortical atrophy, including lateral parietal and temporal cortex, posterior cingulate cortex, precuneus, and medial temporal lobe areas. Delayed memory scores were associated with cortical atrophy in temporoparietal and medial temporal lobe regions. No significant relationships were observed between episodic memory measures and cortical atrophy in asymptomatic subjects. Conclusions: Different episodic memory measures were associated with cortical atrophy in specific brain regions in adults with Down syndrome and Alzheimer's disease. These results overlap with those described in sporadic Alzheimer's disease and further support the similarities between Down syndrome-associated Alzheimer's disease and that in the general population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combining fMRI and DISC1 gene haplotypes to understand working memory-related brain activity in schizophrenia

  • Guardiola-Ripoll, Maria|||0000-0001-6949-5687
  • Sotero-Moreno, Alejandro
  • Almodóvar Payá, Carmen|||0000-0002-1952-1581
  • Hostalet, Noemí
  • Guerrero-Pedraza, Amalia|||0000-0001-7567-9407
  • Ramiro, Núria
  • Ortiz-Gil, Jordi|||0000-0001-7910-8062
  • Arias, Barbara|||0000-0001-9181-2132
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Soler-Vidal, Joan
  • Salvador, Raymond|||0000-0001-5557-1562
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Fatjó-Vilas, Mar|||0000-0001-9963-6241
The DISC1 gene is one of the most relevant susceptibility genes for psychosis. However, the complex genetic landscape of this locus, which includes protective and risk variants in interaction, may have hindered consistent conclusions on how DISC1 contributes to schizophrenia (SZ) liability. Analysis from haplotype approaches and brain-based phenotypes can contribute to understanding DISC1 role in the neurobiology of this disorder. We assessed the brain correlates of DISC1 haplotypes associated with SZ through a functional neuroimaging genetics approach. First, we tested the association of two DISC1 haplotypes, the HEP1 (rs6675281-1000731-rs999710) and the HEP3 (rs151229-rs3738401), with the risk for SZ in a sample of 138 healthy subjects (HS) and 238 patients. This approach allowed the identification of three haplotypes associated with SZ (HEP1-CTG, HEP3-GA and HEP3-AA). Second, we explored whether these haplotypes exerted differential effects on n-back associated brain activity in a subsample of 70 HS compared to 70 patients (diagnosis × haplotype interaction effect). These analyses evidenced that HEP3-GA and HEP3-AA modulated working memory functional response conditional to the health/disease status in the cuneus, precuneus, middle cingulate cortex and the ventrolateral and dorsolateral prefrontal cortices. Our results are the first to show a diagnosis-based effect of DISC1 haplotypes on working memory-related brain activity, emphasising its role in SZ.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of Alzheimer Disease with Life Expectancy in People with Down Syndrome

  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Garzón Chavez, Diana
  • Klitgaard Christensen, Maria
  • Valle-Tamayo, Natalia|||0000-0001-9322-3710
  • Plana Ripoll, Oleguer|||0000-0002-6470-7465
  • Rasmussen, Sonja A.
  • Roqué i Figuls, Marta|||0000-0003-0043-1364
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Benejam, Bessy|||0000-0002-6789-8615
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Padilla, Concepción|||0000-0003-4102-6787
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Fernández, Susana|||0000-0002-9777-1156
  • Belbin, Olivia|||0000-0002-6109-6371
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Blesa, Rafael|||0000-0003-4026-2884
  • Lleó, Alberto|||0000-0002-2568-5478
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Fortea, Juan|||0000-0002-1340-638X
Importance: People with Down syndrome have a high risk of developing Alzheimer disease dementia. However, penetrance and age at onset are considered variable, and the association of this disease with life expectancy remains unclear because of underreporting in death certificates. Objective: To assess whether the variability in symptom onset of Alzheimer disease in Down syndrome is similar to autosomal dominant Alzheimer disease and to assess its association with mortality. Design, Setting, and Participants: This study combines a meta-analysis with the assessment of mortality data from US death certificates (n = 77347 case records with a International Classification of Diseases code for Down syndrome between 1968 to 2019; 37900 [49%] female) and from a longitudinal cohort study (n = 889 individuals; 46% female; 3.2 [2.1] years of follow-up) from the Down Alzheimer Barcelona Neuroimaging Initiative (DABNI). Main Outcomes and Measures: A meta-analysis was conducted to investigate the age at onset, age at death, and duration of Alzheimer disease dementia in Down syndrome. PubMed/Medline, Embase, Web of Science, and CINAHL were searched for research reports, and OpenGray was used for gray literature. Studies with data about the age at onset or diagnosis, age at death, and disease duration were included. Pooled estimates with corresponding 95% CIs were calculated using random-effects meta-analysis. The variability in disease onset was compared with that of autosomal dominant Alzheimer disease. Based on these estimates, a hypothetical distribution of age at death was constructed, assuming fully penetrant Alzheimer disease. These results were compared with real-world mortality data. Results: In this meta-analysis, the estimate of age at onset was 53.8 years (95% CI, 53.1-54.5 years; n = 2695); the estimate of age at death, 58.4 years (95% CI, 57.2-59.7 years; n = 324); and the estimate of disease duration, 4.6 years (95% CI, 3.7-5.5 years; n = 226). Coefficients of variation and 95% prediction intervals of age at onset were comparable with those reported in autosomal dominant Alzheimer disease. US mortality data revealed an increase in life expectancy in Down syndrome (median [IQR], 1 [0.3-16] years in 1968 to 57 [49-61] years in 2019), but with clear ceiling effects in the highest percentiles of age at death in the last decades (90th percentile: 1990, age 63 years; 2019, age 65 years). The mortality data matched the limits projected by a distribution assuming fully penetrant Alzheimer disease in up to 80% of deaths (corresponding to the highest percentiles). This contrasts with dementia mentioned in 30% of death certificates but is in agreement with the mortality data in DABNI (78.9%). Important racial disparities persisted in 2019, being more pronounced in the lower percentiles (10th percentile: Black individuals, 1 year; White individuals, 30 years) than in the higher percentiles (90th percentile: Black individuals, 64 years; White individuals, 66 years). Conclusions and Relevance: These findings suggest that the mortality data and the consistent age at onset were compatible with fully penetrant Alzheimer disease. Lifespan in persons with Down syndrome will not increase until disease-modifying treatments for Alzheimer disease are available.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cortical microstructure in primary progressive aphasia, a multicenter study

  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Montal, Victor|||0000-0002-5714-9282
  • Borrego-Écija, Sergi|||0000-0003-2557-0010
  • Mandelli, Maria Luisa|||0000-0002-2518-2520
  • Falgàs, Neus|||0000-0002-3404-2765
  • Welch, Ariane E.
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Belbin, Olivia|||0000-0002-6109-6371
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Bargalló, Núria|||0000-0001-6284-5402
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Blesa, Rafael|||0000-0003-4026-2884
  • Dickerson, Bradford C.
  • Rosen, Howard J.|||0000-0001-9281-7402
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Lleó, Alberto|||0000-0002-2568-5478
  • Gorno-Tempini, Maria Luisa
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Fortea, Juan|||0000-0002-1340-638X
Background: Cortical mean diffusivity is a novel imaging metric sensitive to early changes in neurodegenerative syndromes. Higher cortical mean diffusivity values reflect microstructural disorganization and have been proposed as a sensitive biomarker that might antedate macroscopic cortical changes. We aimed to test the hypothesis that cortical mean diffusivity is more sensitive than cortical thickness to detect cortical changes in primary progressive aphasia (PPA). Methods: In this multicenter, case-control study, we recruited 120 patients with PPA (52 non-fluent, 31 semantic, and 32 logopenic variants; and 5 GRN-related PPA) as well as 89 controls from three centers. The 3-Tesla MRI protocol included structural and diffusion-weighted sequences. Disease severity was assessed with the Clinical Dementia Rating scale. Cortical thickness and cortical mean diffusivity were computed using a surface-based approach. Results: The comparison between each PPA variant and controls revealed cortical mean diffusivity increases and cortical thinning in overlapping regions, reflecting the canonical loci of neurodegeneration of each variant. Importantly, cortical mean diffusivity increases also expanded to other PPA-related areas and correlated with disease severity in all PPA groups. Cortical mean diffusivity was also increased in patients with very mild PPA when only minimal cortical thinning was observed and showed a good correlation with measures of disease severity. Conclusions: Cortical mean diffusivity shows promise as a sensitive biomarker for the study of the neurodegeneration-related microstructural changes in PPA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Dissecting ultra-processed foods and drinks, Do they have a potential to impact the brain?

  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Solanas i Garcia, Montserrat|||0000-0003-2949-1344
  • Escorihuela, Rosa M|||0000-0001-9368-5173
Ultra-processed foods and drinks (UPF) are formulation of ingredients, mostly of exclusive industrial use, that result from a series of industrial processes. They usually have a low nutrient but high energy density, with a high content of saturated and trans fats, and added sugars. In addition, they have characteristic organoleptic properties, and usually contain sophisticated additives, including artificial sweeteners, to intensify their sensory qualities and imitate the appearance of minimally processed foods. In addition, recent research has warned about the presence of chemicals (e.g., bisphenol) and neo-formed contaminants in these products. UPF production and consumption growth have been spectacular in the last decades, being specially consumed in children and adolescents. UPF features have been associated with a range of adverse health effects such as overeating, the promotion of inflammatory and oxidative stress processes, gut dysbiosis, and metabolic dysfunction including problems in glucose regulation. The evidence that these UPF-related adverse health effects may have on the neural network implicated in eating behavior are discussed, including the potential impact on serotonergic and dopaminergic neurotransmission, brain integrity and function. We end this review by placing UPF in the context of current food environments, by suggesting that an increased exposure to these products through different channels, such as marketing, may contribute to the automatic recruitment of the brain regions associated with food consumption and choice, with a detrimental effect on inhibitory-related prefrontal cortices. While further research is essential, preliminary evidence point to UPF consumption as a potential detrimental factor for brain health and eating behavior.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Binge-eating precursors in children and adolescents, neurodevelopment, and the potential contribution of ultra-processed foods

  • Via, Esther|||0000-0002-2331-3232
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
Binge-eating disorder (BED) is a highly prevalent disorder. Subthreshold BED conditions (sBED) are even more frequent in youth, but their significance regarding BED etiology and long-term prognosis is unclear. A better understanding of brain findings associated with BED and sBED, in the context of critical periods for neurodevelopment, is relevant to answer such questions. The present narrative review starts from the knowledge of the development of emotional self-regulation in youth, and the brain circuits supporting emotion-regulation and eating behaviour. Next, neuroimaging studies with sBED and BED samples will be reviewed, and their brain-circuitry overlap will be examined. Deficits in inhibition control systems are observed to precede, and hyperactivity of reward regions to characterize, sBED, with overlapping findings in BED. The imbalance between reward/inhibition systems, and the implication of interoception/homeostatic processing brain systems should be further examined. Recent knowledge of the potential impact that the high consumption of ultra-processed foods in paediatric samples may have on these sBED/BED-associated brain systems is then discussed. There is a need to identify, early on, those sBED individuals at risk of developing BED at neurodevelopmental stages when there is a great possibility of prevention. However, more neuroimaging studies with sBED/BED pediatric samples are needed.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

  • Ceccato, Adrián
  • Forne Izquierdo, Carles
  • Bos, Lieuwe D.
  • Camprubí Rimblas, Marta
  • Areny Balagueró, Aina
  • Campaña Duel, Elena
  • Quero Blanca, Sara
  • Diaz Santos, Emili
  • Roca, Oriol
  • Gonzalo Calvo, David de
  • Fernández Barat, Laia
  • Motos, Anna
  • Ferrer Roca, Ricard
  • Riera del Brío, Jordi
  • Lorente Balanza, José Ángel
  • Peñuelas Rodríguez, Óscar
  • Menéndez, Rosario
  • Amaya Villar, Rosario
  • Añón Elizalde, José Manuel
  • Balan Mariño, Ana
  • Barberà, Carme
  • Barberán, José
  • Blandino Ortiz, Aaron Rolando
  • Boado Varela, María Victoria
  • Bustamante Munguira, Elena
  • Caballero, Jesús
  • Carbajales Pérez, Cristina
  • Carbonell, Nieves
  • Catalán González, Mercedes
  • Franco, Nieves
  • Galbán, Cristóbal
  • Gumucio Sanguino, Victor Daniel
  • Torre, María del Carmen de la
  • Estella, Ángel
  • Gallego Curto, Elena
  • García Garmendia, José Luis
  • Garnacho Montero, José
  • Gómez García, José Manuel
  • Huerta, Arturo
  • Jorge García, Ruth Noemí
  • Loza Vázquez, Ana
  • Marín Corral, Judith
  • Martínez de la Gándara, Amalia
  • Martín Delgado, María Cruz
  • Martínez Varela, Ignacio
  • López Messa, Juan
  • Muñiz Albaiceta, Guillermo
  • Nieto, María Teresa
  • Novo, Mariana Andrea
  • Peñasco Martín, Yhivian
  • Pozo Laderas, Juan Carlos
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Ricart Martí, Pilar
  • Roche Campo, Ferrán
  • Rodríguez Oviedo, Alejandro Hugo
  • Sagredo Meneses, Víctor
  • Sánchez Miralles, Angel
  • Sancho Chinesta, Susana
  • Socias Crespí, Lorenzo
  • Solé Violan, Jordi
  • Suarez Sipmann, Fernando
  • Tamayo Lomas, Luis
  • Trenado Álvarez, José
  • Úbeda Iglesias, Alejandro
  • Valdivia, Luis Jorge
  • Vidal Cortés, Pablo
  • Bermejo Martín, Jesús Francisco
  • González Gutiérrez, Jéssica
  • Barbé Illa, Ferran
  • Calfee, Carolyn S.
  • Artigas Raventós, Antonio
  • Torres Martí, Antoni
12 p., Background Acute respiratory distress syndrome (ARDS) can be classifed into sub-phenotypes according to diferent infammatory/clinical status. Prognostic enrichment was achieved by grouping patients into hypoinfammatory or hyperinfammatory sub-phenotypes, even though the time of analysis may change the classifcation according to treatment response or disease evolution. We aimed to evaluate when patients can be clustered in more than 1 group, and how they may change the clustering of patients using data of baseline or day 3, and the prognosis of patients according to their evolution by changing or not the cluster. Methods Multicenter, observational prospective, and retrospective study of patients admitted due to ARDS related to COVID-19 infection in Spain. Patients were grouped according to a clustering mixed-type data algorithm (k-proto? types) using continuous and categorical readily available variables at baseline and day 3. Results Of 6205 patients, 3743 (60%) were included in the study. According to silhouette analysis, patients were grouped in two clusters. At baseline, 1402 (37%) patients were included in cluster 1 and 2341(63%) in cluster 2. On day 3, 1557(42%) patients were included in cluster 1 and 2086 (57%) in cluster 2. The patients included in cluster 2 were older and more frequently hypertensive and had a higher prevalence of shock, organ dysfunction, infammatory bio? markers, and worst respiratory indexes at both time points. The 90-day mortality was higher in cluster 2 at both clus? tering processes (43.8% [n=1025] versus 27.3% [n=383] at baseline, and 49% [n=1023] versus 20.6% [n=321] on day 3). Four hundred and ffty-eight (33%) patients clustered in the frst group were clustered in the second group on day 3. In contrast, 638 (27%) patients clustered in the second group were clustered in the frst group on day 3. Conclusions During the frst days, patients can be clustered into two groups and the process of clustering patients may change as they continue to evolve. This means that despite a vast majority of patients remaining in the same cluster, a minority reaching 33% of patients analyzed may be re-categorized into diferent clusters based on their progress. Such changes can signifcantly impact their prognosis., Instituto de Salud Carlos III, Centro de Investigación Biomedica En Red-Enfermedades Respiratorias (CIBERES), Unión Europea
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Machine-learning analysis identifies "elite" viral controllers with increased survival and homeostatic responses in critical COVID-19

  • García Mateo, Nadia
  • Álvaro Meca, Alejandro
  • Postigo, Tamara
  • Ortega, Alicia
  • Fuente, Amanda de La
  • Almansa, Raquel
  • Jorge, Noelia
  • González González, Laura
  • Sánchez Recio, Lara
  • Martínez, Isidoro
  • Martín Vicente, María Dolores
  • Muñoz Gómez, María José
  • Más, Vicente
  • Vázquez, Mónica
  • Cano, Olga
  • Vélez Serrano, Daniel
  • Tamayo, Luis
  • Berezo, José Ángel
  • Herrán Monge, Rubén
  • Blanco, Jesús
  • Enríquez, Pedro
  • Ryan Murúa, Pablo
  • Martínez de la Gándara, Amalia de la
  • Rodríguez, Covadonga
  • Andrade, Gloria
  • Bustamante Munguira, Elena
  • Renedo Sánchez Girón, Gloria
  • Cicuéndez Ávila, Ramón
  • Bustamante Munguira, Juan
  • Trapiello, Wysali
  • Gallego Curto, Elena
  • Úbeda Iglesias, Alejandro
  • Salgado Villén, María
  • Berruguilla Pérez, Enrique
  • Torre, María del Carmen de la
  • Güel, Estel
  • Casadiego, Fernando
  • Estella, Ángel
  • Recuerda Núñez, María
  • Sánchez Calvo, Juan Manuel
  • Campos Fernández, Sandra
  • Peñasco Martín, Yhivian
  • García Unzueta, María Teresa
  • Martínez Varela, Ignacio
  • Bouza Vieiro, María Teresa
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Moreno Romero, Ana
  • Socias Crespí, Lorenzo
  • López Messa, Juan
  • Pérez Bastida, Leire
  • Vidal Cortés, Pablo
  • Río Carbajo, Lorena del
  • Nieto del Olmo, Jorge del
  • Prol Silva, Estefanía
  • Sagredo Meneses, Víctor
  • Albalá Martínez, Noelia
  • González Rivera, Milagros
  • Gómez, José Manuel
  • Carbonell, Nieves
  • Blasco, María Luisa
  • Gonzalo Calvo, David de
  • González, Jessica
  • Caballero, Jesús
  • Barberà, Carme
  • Martín Delgado, María Cruz
  • Valdivia, Luis Jorge
  • Martín López, Caridad
  • Nieto, María Teresa
  • Jorge García, Ruth Noemí
  • Maseda, Emilio
  • Loza Vázquez, Ana
  • Eiros, José María
  • Motos, Anna
  • Fernández Barat, Laia
  • Casenco Ribas, Joan
  • Ceccato, Adrián
  • Barbé, Ferran
  • Kelvin, David J.
  • Bermejo Martín, Jesús Francisco
  • Tedim, Ana P.
  • Resino, Salvador
  • Torres, Antoni
9 p., Instituto de Salud Carlos III, Canadian Institutes of Health Research, Fondo Europeo de Desarrollo Regional, European Social Fund, European Society of Clinical Microbiology and Infectious Diseases
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Longitudinal recovery trajectories and ventilatory modalities in COVID-19 acute respiratory distress syndrome survivors

  • González, Jessica
  • Benítez, Iván D.
  • Santisteve, Sally
  • Vila, Anna
  • Aguilà, Maria
  • Torres, Gerard
  • Sánchez Cucó, Anna
  • Malla Bañeres, Mar
  • Moncusí Moix, Anna
  • Batlle, Jordi de
  • Gracia Lavedan, Esther
  • Ceccato, Adrián
  • Ferrer, Ricard
  • Motos, Anna
  • Riera, Jordi
  • Fernández, Laia
  • Menéndez, Rosario
  • Lorente, José Ángel
  • Peñuelas, Oscar
  • García, Darío
  • Roca, Oriol
  • Peñasco, Yhivian
  • Ricart, Pilar
  • Martín Delgado, María Cruz
  • Aguilera, Luciano
  • Rodriguez, Alejandro
  • Boado Varela, María Victoria
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Pozo Laderas, Juan Carlos
  • Solé Violan, Jordi
  • Adell Serrano, Berta
  • Andrea Novo, Mariana
  • Barberán, José
  • Amaya Villar, Rosario
  • Gonzalo Calvo, David de
  • Torres, Antoni
  • Barbé, Ferran
  • Roche Campo, Ferrán
CIBERESUCICOVID Group: José Garnacho-Montero, Jose M. Gómez, Aaron Blandino Ortiz, Luis Tamayo Lomas, Alejandro Úbeda, Mercedes Catalán-González, Angel Sánchez-Miralles, Ignacio Martinez Varela, Ruth Noemí Jorge García, Nieves Franco, Victor D. Gumucio-Sanguino, Elena Bustamante-Munguira, Luis Jorge Valdivia, Jesús Caballero, Elena Gallego, Amalia Martínez de la Gándara, Alvaro Castellanos-Ortega, Josep Trenado, Judith Marin-Corral, Guillermo M. Albaiceta, Maria del Carmen de la Torre, Ana Loza-Vázquez, Pablo Vidal, Jose M. Añón, Cristina Carbajales Pérez, Victor Sagredo, Nieves Carbonell, Lorenzo Socias, Carme Barberà, Angel Estella, Emili Diaz, Fatty Seck, Adriano D.S. Targa, Inmaculada Salvador-Adell, Luis Urrelo-Cerrón, Mireia Serra-Fortuny and Esther Sauras-Colón., Background The impact of different ventilatory support modalities and timing of intubation on longitudinal lung recovery trajectories in patients with severe coronavirus disease 2019 (COVID-19) is unknown. Methods This was a multicentre, prospective observational study conducted in 52 Spanish intensive care units (ICUs) involving critically ill COVID-19 patients admitted between 25 February 2020 and 8 February 2021. 1854 COVID-19 patients were followed after hospital discharge at 3, 6 and 12 months with diffusing capacity of the lung for carbon monoxide (DLCO) measurements and chest imaging. Patients were classified regarding the ventilatory support received during the ICU stay: noninvasive mechanical ventilation (NIMV), high-flow nasal cannula (HFNC) and invasive mechanical ventilation (IMV), divided into early IMV (intubation within 24 h) and late IMV (intubation after 24 h). The primary objective was to evaluate the impact of the different respiratory support modalities during the ICU stay and the time of intubation on DLCO measurements and their recovery trajectories over a 1-year follow-up. Secondary outcomes included other pulmonary function parameters and chest imaging findings. Results A total of 360 (19.4%) and 290 (15.6%) patients received HFNC and NIMV, respectively. 1204 (64.9%) patients underwent IMV; 966 received early IMV and 238 received late IMV. The latter exhibited a significantly worse percentage predicted DLCO during the 1-year follow-up with adjusted differences of 6.9 (95% CI 3.9-10; p<0.001), 4.2 (95% CI 1.1-7.2; p=0.007) and 4.9 (95% CI 1.7-8.2; p=0.003) at 3, 6 and 12 months compared with early IMV. NIMV patients exhibited greater lung damage at follow-up than those under HFNC with an adjusted difference of percentage predicted DLCO of 5.2 (95% CI 1.7-8.7; p=0.003) at 6 months and greater presence of radiological abnormalities during follow-up. Matched and sensitivity analysis showed results consistent with those reported. Conclusions Delay in intubation implies the worst outcomes; however, patients with NIMV exhibited a slower lung recovery in terms of DLCO measurements and more radiological abnormalities compared with HFNC patients. These results should be used to optimise follow-up protocols for COVID-19 acute respiratory distress syndrome (ARDS) survivors., Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, Fondo Social Europeo Plus, Centro de Investigación Biomédica en Red, Fundación Francisco Soria Melguizo
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes

  • Galli, Flavia
  • Forin, Edoardo
  • Motos, Ana
  • Molina Saldarriaga, Francisco José
  • Gabarrús, Albert
  • Canseco, Joan
  • Fernández Barat, Laia
  • Barbeta, Enric
  • Calabretta, Davide
  • Ceccato, Adrián
  • Bermejo Martín, Jesús Francisco
  • Ferrer, Ricard
  • Riera, Jordi
  • Peñuelas, Oscar
  • Lorente, José Ángel
  • Gonzalo Calvo, David de
  • Menéndez, Rosario
  • González, Jessica
  • Palomeque, Andrea
  • Soler Comas, Alba
  • Amaya Villar, Rosario
  • Anon, José Manuel
  • Balan Mariño, Ana
  • Barberà, Carme
  • Barberán, José
  • Blandino Ortiz, Aaron Rolando
  • Bustamante Munguira, Elena
  • Caballero, Jesús
  • Cantón Bulnes, María Luisa
  • Carbajales Pérez, Cristina
  • Carbonell, Nieves
  • Catalán González, Mercedes
  • Frutos, Raúl de
  • Franco, Nieves
  • Galbán, Cristóbal
  • López Lago, Ana
  • Gumucio Sanguino, Víctor D.
  • Torre, María del Carmen de la
  • Díaz, Emilio
  • Estella, Ángel
  • Gallego Curto, Elena
  • García Garmendia, José Luis
  • Gómez, José Manuel
  • Huerta, Arturo
  • Jorge García, Ruth Noemí
  • Loza Vázquez, Ana
  • Marín Corral, Judith
  • Martín Delgado, María Cruz
  • Martínez de la Gándara, Amalia
  • Martínez Varela, Ignacio
  • López Messa, Juan
  • Albaiceta, Guillermo M.
  • Andrea Novo, Mariana
  • Peñasco, Yhivian
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Pozo Laderas, Juan Carlos
  • Ricart, Pilar
  • Sagredo, Víctor
  • Sánchez Miralles, Ángel
  • Sancho Chinesta, Susana
  • Roche Campo, Ferran
  • Socias Crespí, Lorenzo
  • Solé Violan, Jordi
  • Suarez Sipmann, Fernando
  • Tamayo Lomas, Luis
  • Trenado, José
  • Úbeda, Alejandro
  • Valdivia, Luis Jorge
  • Vidal, Pablo
  • Boado, María Victoria
  • Rodriguez, Alejandro
  • Ferrer, Miquel
  • Barbé, Ferran
  • Torres, Antoni
  • CIBERESUCICOVID Project investigators
CIBERESUCICOVID Project investigators (COV20/00110, ISCIII): Rafael Mañez, Felipe Rodríguez de Castro, María Mora Aznar, Mateu Torres, María Martinez, Cynthia Alegre, Sofía Contreras, Javier Trujillano, Montse Vallverdú, Miguel León, Mariona Badía, Begoña Balsera, Lluís Servià, Judit Vilanova, Silvia Rodríguez, Neus Montserrat, Silvia Iglesias, Javier Prados, Sula Carvalho, Mar Miralbés, Josman Monclou, Gabriel Jiménez, Jordi Codina, Estela Val, Pablo Pagliarani, Jorge Rubio, Dulce Morales, Andrés Pujol, Àngels Furro, Beatriz García, Gerard Torres, Javier Vengoechea, Silvia Gomez, Lorena Forcelledo Espina, Emilio García Prieto, Paula Martín Vicente, Cecilia Del Busto Martínez, María Aguilar Cabello, Carmen Eulalia Martínez Fernández, María Luisa Blasco Cortés, Ainhoa Serrano Lázaro, Mar Juan Díaz, María Teresa Bouza Vieiro, Inés Esmorís Arijón, David Campi Hermoso, Rafaela Nogueras Salinas, Teresa Farre Monjo, Ramon Nogue Bou, Gregorio Marco Naya, Núria Ramon Coll, Juan Carlos Montejo-González, Gloria Renedo Sanchez-Giron, Juan Bustamante-Munguira, Ramon Cicuendez Avila, Nuria Mamolar Herrera, Alexander Agrifoglio, Lucia Cachafeiro, Emilio Maseda, Albert Figueras, Maria Teresa Janer, Laura Soliva, Marta Ocón, Luisa Clar, JIgnacio Ayestarán, Sandra Campos Fernández, Eva Forcadell-Ferreres, Immaculada Salvador-Adell, Neus Bofill, Berta Adell-Serrano, Josep Pedregosa Díaz, Núria Casacuberta-Barberà, Luis Urrelo-Cerrón, Àngels Piñol-Tena, Pablo Ryan Murúa, Covadonga Rodríguez Ruíz, Laura Carrión García, Juan ILazo Álvarez, Desire Macias Guerrero, Daniel Tognetti, Carlos García Redruello, David Mosquera Rodríguez, Eva María Menor Fernández, Sabela Vara Adrio, Vanesa Gómez Casal, Marta Segura Pensado, María Digna Rivas Vilas, Amaia García Sagastume, Raul de Pablo Sánchez, David Pestaña Laguna, Tommaso Bardi, Carmen Gómez Gonzalez, Maria Luisa Gascón Castillo, José Garnacho-Montero, Joan Ramon Masclans, Ana Salazar Degracia, Judit Bigas, Rosana Muñoz-Bermúdez, Clara Vilà-Vilardel, Francisco Parrilla, Irene Dot, Ana Zapatero, Yolanda Díaz, María Pilar Gracia, Purificación Pérez, Andrea Castellví, Cristina Climent, Lidia Serra, Laura Barbena, Iosune Cano, Alba Herraiz, Pilar Marcos, Laura Rodríguez, Maria Teresa Sariñena, Ana Sánchez, Juan Fernando Masa Jimenez, Gemma Gomà, Mercedes Ibarz, Diego De Mendoza, Victoria Alcaraz-Serrano, Joan Ramon Badia, Manuel Castella, Leticia Bueno, Catia Cillóniz, Pamela Conde, Javier Fernández, Karsa Kiarostami, Alexandre López-Gavín, Cecilia L Mantellini, Carla Speziale, Nil Vázquez, Hua Yang, Minlan Yang, Carlos Ferrando, Pedro Castro, Marta Arrieta, Jose Maria Nicolas, Rut Andrea, Marta Barroso, Sergio Álvarez, Dario Garcia-Gasulla, Adrián Tormos, Cesar Aldecoa, Rubén Herrán-Monge, José Ángel Berezo García, Pedro Enríquez Giraudo, Pablo Cardinal Fernández, Alberto Rubio López, Orville BáezPravia, Leire Pérez Bastida, Antonjo Alvarez Ruiz, Anna Parera Pous, Ana López Lago, Eva Saborido Paz, Patricia Barral Segade, Manuel Valledor Mendez, Luciano Aguilera, Esther López-Ramos, Ángela Leonor Ruiz-García, Belén Beteré, Rafael Blancas, Cristina Dólera, Gloria Perez Planelles, Enrique Marmol Peis, Maria Dolores Martinez Juan, Miriam Ruiz Miralles, Eva Perez Rubio, Maria Van der Hofstadt Martin-Montalvo, Tatiana Villada Warrington, Sara Guadalupe Moreno Cano, Federico Gordo, Basilisa Martinez Palacios, Maria Teresa Nieto, Sergio Ossa, Ana Ortega, Miguel Sanchez, Bitor Santacoloma, Introduction. COVID-19 severely impacted global health, especially older adults and those with comorbidities. Immunosuppressed patients are at high risk for severe outcomes, yet studies yield conflicting mortality rates for this group. This study examines the clinical characteristics and outcomes of immunosuppressed (IS) versus non-immunosuppressed (nIS) patients with COVID-19 in ICUs.MethodsA multicenter, observational case-control study included 5,824 ICU patients with COVID-19 from the CIBERESUCICOVID study. Patients were categorized as IS or nIS based on history of transplantation, HIV, active neoplasia, and use of immunosuppressive drugs or corticosteroids. The primary outcome was 90-day mortality; secondary outcomes included in-hospital, 15-day, 30-day and 1-year mortality, ICU-free days, ventilator-free days, and hospital length of stay. Subgroup analyses examined vaccination status and tocilizumab treatment. Propensity score (PS) matching was used to obtain balance among the baseline variables in the two groups.ResultsIS patients (n = 689, 11.8%) were older, had more comorbidities, and higher APACHE-II scores. After PS matching, IS patients had higher 90-day mortality (39 vs. 33%; HR 1.30, 95% CI 1.04 to 1.62), as well as higher in-hospital (37 vs. 29%; sHR 1.35, 95% CI 1.08 to 1.69), 30-day (28 vs 23%; HR 1.31, 95% CI 1.01 to 1.69) and 1-year mortality (45 vs. 38%; HR 1.26, 95% CI 1.02 to 1.57). Among IS patients, transplant recipients had significantly higher 90-day mortality after matching (HR 4.45, 95% CI 1.46 to 13.58). Vaccinated IS patients showed higher mortality than vaccinated nIS patients, though differences were not significant after PS matching. Tocilizumab treatment in IS patients was associated with reduced mortality; multivariable analysis confirmed a significant decrease in in-hospital mortality (sHR 0.56, 95% CI 0.42 to 0.76).ConclusionCritical immunosuppressed patients with COVID-19 have higher mortality, particularly transplant recipients. Tocilizumab shows potential benefits for IS patients. These findings highlight the need for tailored therapeutic strategies for immunosuppressed individuals with severe COVID-19. Further research is needed to confirm these results in the current clinical context., Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, Centro de Investigación Biomédica en Red, Unión Española de Entidades Aseguradoras y Reaseguradoras, European Social Fund